Intelligent Entity-Relationship Mapping & Discovery
| Subject | Relationship | Object |
|---|---|---|
| Ghosh | instance of | S |
| S | has part | Author |
| S | contains administrative territorial entity | Johannessen |
| S | contains administrative territorial entity | Iramiot |
| S | contains administrative territorial entity | Chabardes |
| S | contains administrative territorial entity | Santacruz |
| S | contains administrative territorial entity | Moccia |
| S | part of | Gruber |
| S | contains administrative territorial entity | Salvemini |
| S | contains administrative territorial entity | Cattaneo |
| Sharma | religious order | H |
| Sharma | religious order | S |
| H | has part | H |
| H | contains administrative territorial entity | Groenewegen |
| H | part of | Bergman |
| H | contains administrative territorial entity | Wodschow |
| H | part of | Sontheimer |
| Bhaskar | religious order | R |
| R | contains administrative territorial entity | Guimaraes |
| K. Narayanan | religious order | K |
| K | named after | Augustin |
| Comprehensive | followed by | Comprehensive |
| Review Of Emerging Trends | main subject | Emerging Trends |
| Emerging Trends | subclass of | Innovative Therapies |
| Emerging Trends | subclass of | Evolving |
| Innovative Therapies In Epilepsy | facet of | Epilepsy |
| Epilepsy | subclass of | Neurological Disorder |
| Epilepsy | drug used for treatment | Treatment |
| Epilepsy | has effect | Quality Of Life |
| Epilepsy | subclass of has effect | Neurological Disorder Seizures |
| Epilepsy | drug used for treatment | Management |
| Epilepsy | subclass of | Syndromes |
| Epilepsy | instance of | Landscape |
| Epilepsy | studied by | Pathophysiology |
| Epilepsy | drug used for treatment | Medications |
| Epilepsy | has part | Many Individuals |
| Epilepsy | has cause | Epilepsy |
| Epilepsy | has effect | Seizure |
| Epilepsy | drug used for treatment | Asms |
| Epilepsy | subclass of | Individuals Living With |
| Epilepsy | studied by | Mechanisms |
| Epilepsy | drug used for treatment | Treatments |
| Epilepsy | subclass of | Neurological Disorders |
| Epilepsy | has effect | Seizures |
| Epilepsy | drug used for treatment | Anticonvulsant |
| Epilepsy | has effect | Affected By Epilepsy |
| Epilepsy | subclass of | Pwe |
| Epilepsy | has effect | Deaths In Pediatric |
| Epilepsy | drug used for treatment | Treatment Options |
| Epilepsy | instance of | Specialized |
| Epilepsy | drug used for treatment | Drug |
| Epilepsy | number of episodes | 135 |
| Epilepsy | drug used for treatment | Cannabidiol |
| Epilepsy | drug used for treatment | Cbd |
| Epilepsy | has cause | Brain |
| Epilepsy | has cause | Specific |
| Epilepsy | has cause | Neural |
| Epilepsy | subclass of | Patients |
| Epilepsy | studied by | Neural Activity |
| Epilepsy | studied by | Brain Sci |
| Epilepsy | drug used for treatment | Significant |
| Epilepsy | studied by | Therapies |
| Epilepsy | drug used for treatment | Treatment Of Epilepsy |
| Epilepsy | instance of | Fact-Sheet |
| Epilepsy | has cause | Associated Factors |
| Epilepsy | has cause | Immunity |
| Epilepsy | studied by | Pediatric |
| Epilepsy | studied by | Epilepsy Surgery |
| Epilepsy | has effect | Epileptic Seizure |
| Epilepsy | studied by | Advanced Practice Providers |
| Epilepsy | studied by | Personalized Medicine |
| Epilepsy | drug used for treatment | Antiepileptogenic Nux Vomica |
| Epilepsy | drug used for treatment | Targeted |
| Pubmed | uses | Peer-Reviewed |
| Pubmed | use | Systematic Search |
| Pubmed | instance of | Search |
| Pubmed | has part | Pubmed |
| Pubmed | instance of | Open-Source |
| Brainsci13091305 | instance of | Brain |
| Brain | part of | Sciences |
| Brain | part of | Cognitive |
| Brain | has part | Structure |
| Brain | has part | Neural Activity |
| Brain | has part | Electrodes |
| Brain | instance of | Region |
| Brain | has effect | Seizures |
| Brain | has part | Neuronal Activity |
| Brain | studied by | Brain Sci |
| Brain | has part | Specific |
| Brain | has part | Electrical Activity |
| Brain | studied by | Electrocorticography |
| Brain | has part | Receptor Systems |
| Brain | connects with | Liver |
| Brain | has part | Neuronal |
| Brain | has effect | Epilepsy |
| Brain | instance of | Regions |
| Brain | has part | Interconnected Brain Regions |
| Brain | connects with | Spinal Cord |
| Simona Lattanzi | occupation | Academic Editor |
| 2020 | point in time | 2020 |
| 2020 | point in time | 2023 |
| 2020 | followed by | 2021 |
| 2020 | point in time | 2026 |
| 2023 | point in time | 2023 |
| Copyright | author | Authors |
| Authors | part of | Affiliated |
| Basel | country | Switzerland |
| Open Access | subclass of | Article |
| Open Access | instance of | Access |
| The Beatles | influenced by | Led Zeppelin |
| The Beatles | work period (start) | 1960 |
| The Beatles | has part | Aretha Franklin |
| Creative Commons | product or material produced | Conditions Of The Creative Commons |
| Creative Commons | product or material produced | Attribution License |
| Cc By | based on | Attribution (Cc By) License |
| Creativecommons | instance of | Commons |
| By | facet of | Licenses |
| A Comprehensive Review Of Emerging Trends And Innovative | main subject | Emerging Trends And Innovative |
| Therapies In Epilepsy Management | facet of | Epilepsy |
| Shampa Ghosh | ranking | 1 |
| Shampa Ghosh | religious order | J |
| Shampa Ghosh | spouse | Soumya Ghosh |
| Shampa Ghosh | spouse | Jitendra Kumar Sinha |
| Jitendra Kumar Sinha | ranking | 1 |
| Jitendra Kumar Sinha | spouse | Shampa Ghosh |
| Soumya Ghosh | sibling | Hitaishi Sharma |
| Soumya Ghosh | occupation | H |
| Soumya Ghosh | spouse | Shampa Ghosh |
| Hitaishi Sharma | sibling | Soumya Ghosh |
| Kannan Badri Narayanan | spouse | Kannan Badri Narayanan |
| Kannan Badri Narayanan | spouse | Rakesh Bhaskar |
| Noida | country | India |
| National Institute Of Nutrition | located in the administrative territorial entity country | Tarnaka India |
| Tarnaka | country | India |
| Hyderabad | country | India |
| Yeungnam University | located in the administrative territorial entity | Gyeongsan |
| Yeungnam University | country | Republic Of Korea |
| Gyeongbuk | country | Republic Of Korea |
| Jksinha | employer | Globoneuro |
| Jitendrakumarsinha | member of | Jitendrakumarsinha |
| Okbadri | member of | Yu |
| Neurological Disorder | subclass of | 2 |
| Neurological Disorder | studied by | Neurology |
| Drug-Resistant Epilepsy | subclass of | Epilepsy |
| Drug-Resistant Epilepsy | subclass of | Treatment Resistance |
| Drug-Resistant Epilepsy | subclass of | Approaches To Address Drug-Resistant Epilepsy |
| Drug-Resistant Epilepsy | subclass of | Epilepsy Management |
| Drug-Resistant Epilepsy | subclass of | Personalized And Adaptive Treatment |
| Drug-Resistant Epilepsy | subclass of | Efficacy |
| Drug-Resistant Epilepsy | subclass of | Severe |
| Drug-Resistant Epilepsy | subclass of | Potential Treatment |
| Drug-Resistant Epilepsy | drug used for treatment | Gies |
| Drug-Resistant Epilepsy | subclass of | Evaluation And Management Of Drug-Resistant Epilepsy |
| Drug-Resistant Epilepsy | drug used for treatment | Neuromodulation |
| Drug-Resistant Epilepsy | drug used for treatment | Ta-Vns |
| Innovative | subclass of | Innovative |
| Clinical Evidence | part of | Principles |
| Applications | subclass of | Application |
| Antiseizure Medications | use | Epilepsy Treatment |
| Antiseizure Medications | subclass of | Medication Adherence |
| Alternative Approaches | subclass of | Limitations |
| Alternative Approaches | opposite of | Conventional Treatments |
| Limitations | subclass of | Challenges |
| The Best Electric Light In The World | author | John F. Kennedy |
| John F. Kennedy | position held | President |
| Vagus Nerve Stimulation | subclass of | Responsive Neurostimulation |
| Vagus Nerve Stimulation | subclass of | Deep Brain Stimulation |
| Vagus Nerve Stimulation | subclass of | Stimulation |
| Vagus Nerve Stimulation | subclass of | Neuromodulation Therapy |
| Vagus Nerve Stimulation | subclass of | Novel Vns |
| Vagus Nerve Stimulation | studied by | Therapeutic Mechanisms Of Vagus Nerve Stimulation |
| Vagus Nerve Stimulation | medical condition treated | Inflammatory Bowel Diseases |
| Vagus Nerve Stimulation | medical condition treated | Epilepsy |
| Vagus Nerve Stimulation | part of | Devices For Vagus Nerve Stimulation |
| Vagus Nerve Stimulation | part of | Combined Neuromodulation |
| Responsive Neurostimulation | subclass of | Neurostimulator |
| Responsive Neurostimulation | subclass of | Neurostimulation |
| Responsive Neurostimulation | instance of | Therapy |
| Mechanisms Of Action | has effect | Clinical Outcomes |
| Mechanisms Of Action | part of | Action |
| Mechanisms Of Action | facet of | Asm |
| Optogenetics | facet of | Epilepsy |
| Optogenetics | uses | Optics |
| Optogenetics | studies | Optogenetics |
| Optogenetics | studies | Neuronal |
| Optogenetics | studies | Neuronal Activity |
| Optogenetics | subclass of | Clinical Applications |
| Optogenetics | studies | Specific |
| Optogenetics | subclass of | Neurostimulation |
| Optogenetics | instance of | Groundbreaking |
| Optogenetics | subclass of | Informed Decision Making |
| Optogenetics | subclass of | Gene Therapies |
| Optogenetics | part of | Systems Neuroscience |
| Seizure | subclass of | Mechanisms |
| Seizure | has cause | Abnormal Electrical Activity |
| Seizure | has cause | Significant |
| Seizure | subclass of | Seizures |
| Seizure | has cause | Asms |
| Seizure | studied by | Pediatric |
| Seizure | subclass of | Onset |
| Seizure | has effect | Seizure |
| Seizure | has cause | Epileptic |
| Seizure | has effect | Manifesting |
| Seizure | has cause | Characteristic |
| Seizure | has effect | Seizure-Related Incident |
| Seizure | has cause | Predictive |
| Seizure | has cause | Occurrence |
| Seizure | has effect | Propagation Of Seizures |
| Seizure | has cause | Excitability |
| Seizure | subclass of | Biomarkers |
| Seizure | has effect | Seizure-Related Differences |
| Seizure | subclass of | Progression |
| Seizure | has part | Seizure Segments |
| Seizure | number of participants | 3 |
| Seizure | subclass of | Early Signs |
| Seizure | has part | 22 |
| Seizure | number of episodes | 24 |
| Seizure | subclass of | Features |
| Seizure | opposite of | Nonseizure Seg |
| Seizure | opposite of | Nonseizure |
| Seizure | instance of | Clinical Utility |
| Seizure | subclass of | Period |
| Seizure | has cause | Diovascular Features |
| Seizure | subclass of | Eralized |
| Seizure | has cause | Neural Activity |
| Seizure | has effect | Sensitivity |
| Seizure | has effect | Reproducibility |
| Seizure | has cause | Seizure-Related |
| Mechanisms | has part | Causes |
| Mechanisms | part of | Mechanisms |
| Cannabidiol | subclass of | Cbd |
| Cannabidiol | subject has role | Adjunct Therapy |
| Cannabidiol | instance of | Natural |
| Cannabidiol | medical condition treated | Epilepsy |
| Cannabidiol | subject has role | Antiepileptic Drug |
| Cannabidiol | subject has role | Oral Doses Of Cannabidiol |
| Cbd | has effect | Significant |
| Cbd | subject has role | Anticonvulsant |
| Cbd | instance of | Thought |
| Cbd | part of | Endocannabinoid System |
| Cbd | instance of | Cbd |
| Cbd | medical condition treated | Epilepsy |
| Cbd | has effect | Effectiveness |
| Cbd | instance of | Cannabinoid |
| Cbd | subject has role | Adjunctive |
| Cbd | instance of | Interact With Certain |
| Cbd | instance of | Safety |
| Cbd | subject has role | Adjunctive Therapy |
| Cbd | part of | Medi- |
| Cbd | subclass of | Transient |
| Cbd | part of | Cbd Products |
| Cbd | instance of | Efficacy |
| Ketogenic Diet | subclass of | Adjunctive Therapies |
| Ketogenic Diet | has part | Cbd |
| Ketogenic Diet | subclass of | Non-Pharmacological Interventions |
| Ketogenic Diet | medical condition treated | Epilepsy |
| Ketogenic Diet | subclass of | Low-Carbohydrate |
| Ketogenic Diet | use | Epilepsy Management |
| Ketogenic Diet | subclass of | Efficacy |
| Ketogenic Diet | has effect | Clinically Meaningful |
| Ketogenic Diet | subject has role | Anticonvulsant |
| Ketogenic Diet | main subject | Ketogenic |
| Ketogenic Diet | subclass of | Benefits |
| Ketogenic Diet | medical condition treated | Seizure Management |
| Ketogenic Diet | different from | Ketogenic Diet |
| Ketogenic Diet | studies | Children |
| Ketogenic Diet | medical condition treated | Alzheimer’S Diseases |
| Ketogenic Diet | medical condition treated | Resistant Epilepsy |
| Ketogenic Diet | has effect | Clinical Effects |
| Treatment Resistance | facet of | Traditional Therapies |
| Treatment Resistance | facet of | Epilepsy |
| Treatment Resistance | facet of | Treatment |
| Treatment Resistance | has part | Significant |
| Treatment Resistance | opposite of | Effectiveness Of Treatment |
| Treatment Resistance | subclass of | Complexities |
| Variability | subclass of | Individual |
| Variability | subclass of | Variability |
| The Importance Of Staying Updated | facet of | Trends |
| Trends | facet of | Retrospective |
| Management | subclass of | Therapeutic |
| Management | medical condition treated | Epilepsy |
| Therapeutic | has part | Benefits |
| Ai | subclass of | Therapies |
| Ai | subclass of | Algorithms |
| Ai | has part | Machine Learning |
| Treatment | medical condition treated | Epilepsy |
| Treatment | practiced by | Physician |
| Treatment | facet of | Seizure Control |
| Treatment | different from | Sufficient |
| Treatment | subclass of | Treatment |
| The Great Gatsby | cast member | Richard Rodgers |
| The Great Gatsby | performer | David Bowie |
| The Great Gatsby | author | Michael Winterbottom |
| The Great Gatsby | composer | Gatsby |
| The Great Gatsby | derivative work | Glee |
| The Great Gatsby | author | Christopher Tolkien |
| The Great Gatsby | composer | Richard Wagner |
| The Great Gatsby | director | Richard Gatsby |
| The Great Gatsby | composer | Richard Strauss |
| The Great Gatsby | based on | The Great Gatsby |
| The Great Gatsby | author | John Galt |
| Synthetic | subclass of | Biochemistry |
| Medicine | has part | Patients |
| Patients | subclass of | Patients |
| Patients | practiced by | Clinicians |
| Patients | part of | Sample |
| Quality Of Life | facet of | Overall |
| Quality Of Life | facet of | Patients |
| Quality Of Life | facet of | Patients Who Have Not Responded |
| Quality Of Life | has cause | Implantation |
| Quality Of Life | facet of | Seizure Control |
| Cannabinoid | use | Personalized Therapy |
| Cannabinoid | different from | Psychoactive Effects |
| Cannabinoid | has part | (A) |
| Cannabinoid | has effect | Hepatic Metabolism |
| Introduction | part of | Introduction |
| Introduction | part of | 1 |
| Seizures | has cause | Epilepsy |
| Seizures | subclass of | Seizures |
| Seizures | has cause | Brain |
| Seizures | drug used for treatment | Surgery |
| Seizures | has cause | Excitatory Activity |
| Seizures | subclass of | Devices |
| Seizures | studied by | Pediatric |
| Seizures | has cause | Seizure |
| Seizures | has cause | Identified |
| Seizures | has cause | Effect |
| Seizures | subclass of | Propagate |
| Seizures | subclass of | Segments |
| World Heritage Site | maintained by | Unesco |
| Abnormal Electrical Activity | has effect | Seizure |
| Cognitive | has part | Brain |
| Cognitive | has part | Memory |
| Cognitive | subclass of | Changes |
| Cognitive | has part | Developmental |
| Traditional | subclass of | Traditional |
| Antiseizure Medication | use | Epilepsy Management |
| Antiseizure Medication | has part | Vagus Nerve Stimulation |
| Epilepsy Management | subclass of | Medical |
| Epilepsy Management | subclass of | Therapeutic |
| Epilepsy Management | subclass of | Therapeutic Option |
| Epilepsy Management | facet of | Epilepsy |
| Epilepsy Management | subclass of | Research |
| Significant | subclass of | Relief |
| Significant | facet of | Significant Challenge |
| Significant | writing system | Significant |
| Significant | medical condition treated | Epilepsy |
| Significant | instance of | Discovery |
| Innovative Therapies | subclass of | Management |
| Innovative Therapies | subclass of | Treatment |
| Innovative Therapies | facet of | Epilepsy |
| Innovative Therapies | subclass of | Therapies |
| Earliest Descriptions | subclass of | Challenges Persist |
| Traditional Asm | subclass of | Asms |
| Asms | facet of | Epilepsy Management |
| Asms | has effect | Seizure |
| Asms | has part | Armamentarium |
| Cognitive Impairment | subclass of | Adverse Effects |
| Systemic Toxicity | subclass of | Toxicity |
| 1305 | point in time | 1305 |
| Brain Science | instance of | Scientific Journal |
| Brain Sci | instance of | Journal |
| Brain Sci | subclass of | Neurobiology |
| Brain Sci | studies | Deep Brain |
| Brain Sci | main subject | Brain |
| Brain Sci | studies | Epilepsy |
| Brain Sci | publisher | Crossref |
| Brain Sci | publisher | Pubmed |
| Journal | inception | 1371 |
| Outcomes | facet of | Outcomes |
| Outcomes | number of participants | 24 |
| Latest Advancements In Epilepsy | facet of | Epilepsy |
| Patient Care | facet of | Patient |
| Cutting-Edge | subclass of | Specific |
| Specific | subclass of | Electrical Activity |
| Specific | subclass of | Epileptic |
| Specific | subclass of | Gene |
| Specific | has effect | Epilepsy |
| Specific | has effect | Epileptogenesis |
| Specific | studied by | Optogenetics |
| Specific | subclass of | Care |
| Specific | subclass of | Neural Circuits |
| Research Directions | subclass of | Research Directions |
| Deep Brain Stimulation | subclass of | Dbs |
| Deep Brain Stimulation | subclass of | Brain Stimulation |
| Deep Brain Stimulation | subclass of | Neuromodulation |
| Deep Brain Stimulation | subclass of | Brain Networks |
| Deep Brain Stimulation | main subject | Current Challenges And Future Directions |
| Deep Brain Stimulation | medical condition treated | Pediatric |
| Deep Brain Stimulation | medical condition treated | Drug-Resistant Epilepsy In Childhood |
| Deep Brain Stimulation | subclass of | Postoperative Issues |
| Gene Therapies | has part | Optogenetics |
| Gene Therapies | subclass of | Treatments |
| Gene Therapies | uses | Gene |
| Gene Therapies | medical condition treated | Epilepsy |
| The Great Train Robbery | participant | John F. Kennedy |
| The Great Train Robbery | author | Robert S. Thompson |
| The Great Train Robbery | cast member | John Wayne |
| The Great Train Robbery | director | Robert Mitchum |
| Alterna-Management | subclass of | Asms |
| Tive | subclass of | Therapeutic |
| Clinical | subclass of | Findings |
| Vns | instance of | Emerging Therapies |
| Vns | subclass of | Rns |
| Vns | subclass of | Neurostimulation Device |
| Vns | subject has role | Anticonvulsant |
| Vns | instance of | Benefits |
| Vns | subclass of | Vns Technology |
| Vns | subclass of | Stimulation |
| Vns | subclass of | Epilepsy |
| Vns | subclass of | Less Invasive Alternative |
| Vns | studied by | Clinical |
| Vns | instance of | Therapeutic |
| Vns | has part | Vns |
| Emerging Therapies | subclass of | Emerging Therapies |
| Tolerability | facet of | Safety |
| Tolerability | facet of | Adherence |
| Safety | has part | Efficacy |
| Seizure Frequency | facet of | Epilepsy |
| Seizure Frequency | has effect | Reduction |
| Seizure Frequency | has cause | Significant |
| Seizure Frequency | facet of | Benefits |
| Seizure Frequency | has cause | Implantation |
| Glee | based on | The Great Gatsby |
| Pathophysiology | studies | Epilepsy |
| Challenges | facet of | Specific |
| The Neurobiology Of Cancer | author | Robert Koch |
| Traditional Approaches To Epilepsy Management | subclass of | Epilepsy Management |
| Modulat | use | Asm |
| Asm | has effect | Effective |
| Asm | subclass of | Traditional |
| Excitability | subclass of | Electrical Activity |
| Excitability | has effect | Seizure Susceptibility |
| Electrical Activity | subclass of | Activity |
| Seizure Control | facet of | Quality Of Life |
| Seizure Control | facet of | Seizure |
| Seizure Control | subclass of | Therapies |
| Seizure Control | subclass of | Benefits |
| Seizure Control | facet of | Tolerability |
| Seizure Control | facet of | Seizure Frequency |
| Seizure Control | subclass of | Dbs |
| Seizure Control | number of participants | 167 |
| Seizure Control | facet of | Epilepsy |
| Targeting | subclass of | Asm |
| Targeting | facet of | Targeting |
| Propagation | part of | Seizure Generation |
| Seizure Generation | has effect | Propagation |
| Seizure Generation | subclass of | Neural Activity |
| Seizure Generation | subclass of | Key Factor |
| Common Asms | subclass of | Asms |
| Valproate | subclass of | Phenytoin |
| Epilepsy Syndrome | subclass of | Seizure Type |
| Health | facet of | Overall |
| Pro- | instance of | Significant |
| Drug-Resistant | subclass of | Asms |
| Drug-Resistant | subclass of | Drug-Resistant |
| Alternative Therapeutic | subclass of | Clinical Challenge |
| Seizure Control With Traditional Therapies | subclass of | Traditional Therapies |
| Recurrent Seizures | subclass of | Refractory To Traditional Asms |
| Social Interaction | part of | Social Lives |
| Opportunities | subclass of | Opportunities |
| Anxiety | has effect | Depression |
| Anxiety | subclass of | Psychological Issues |
| Depression | has part | 2 |
| Complex | subclass of | Multifactorial |
| Complex | subclass of | Neurological Disorder |
| Complex | subclass of | Heterogeneous Disorder |
| Differential | facet of | Patient |
| Effective | has cause | Asm |
| Structure | part of | Brain |
| Function | has part | 20 |
| 20 | instance of | Age Group |
| Psychotherapy | subclass of | Therapies |
| Pharmacokinetic Variability | has effect | Treatment Resistance |
| Metabolized | part of | Distributed |
| Efficacy | subclass of | Therapeutic |
| Efficacy | subclass of | Medications |
| Efficacy | subclass of | Stimulation |
| Efficacy | has effect | Seizure Frequency |
| Efficacy | facet of | Patient Convenience |
| Efficacy | subclass of | Treatment |
| Efficacy | has effect | Seizure |
| Efficacy | subclass of | Gene Therapies |
| Efficacy | part of | Long-Term Safety |
| Drug Interaction | has cause | Genetic Factors |
| Drug Interaction | has cause | Healthcare Providers |
| Drug Interaction | has cause | Med-Providers |
| Drug Response | subclass of | Treatment |
| 24 | number of participants | 24 |
| Suboptimal Seizure Control | subclass of | Seizure Control |
| Medication | subclass of | Medications |
| Medication | number of participants | 4 |
| Neurotransmitter Receptor | subclass of | Ion Channel |
| Ion Channel | subclass of | Gene |
| Neuron | part of | Networks |
| Neuron | has part | Specific |
| Neuron | has effect | Activity |
| Neuron | connects with | Neurons |
| Traditional Asms | subclass of | Asms |
| Complete Seizure Control | subclass of | Seizure Control |
| Compliance Issues | facet of | Compliance |
| Aed | has part | Adherence To Prescribed Aed Regimens |
| Seizure Management | facet of | Seizure |
| Medication Compliance | has part | Poor Medication Compliance |
| Medication Compliance | facet of | Asms |
| Forgetfulness | subclass of | Medication Side Effect |
| Treatment Plan | facet of | Treatment |
| Tolerance | subclass of | Adaptation |
| Tolerance | subclass of | Effect |
| Tolerance | subclass of | Loss Of Effect |
| Adaptability | subclass of | Compensatory Mechanisms |
| Approaches | subclass of | Approaches |
| Side Effect | has effect | Effect |
| Side Effect | subclass of | Medical Intervention |
| Side Effect | facet of | Treatment |
| Side Effect | subclass of | Minimizing |
| Side Effect | facet of | Continuous, Open-Loop Stimulation |
| Side Effect | facet of | Situation |
| Side Effect | facet of | Interactions |
| Significant Adverse | has cause | Significant |
| Drowsiness | subclass of | Dizziness |
| Seizure Reduction | instance of | Benefits |
| Seizure Reduction | has effect | Improved Seizure |
| Seizure Reduction | facet of | Seizure |
| Benefits | has part | Seizures |
| Benefits | opposite of | Benefits |
| Benefits | part of | Therapeutic |
| Discontinuation | subclass of | Treatment |
| Individualized Approach | subclass of | Individualized |
| Individualized | subclass of | Assessment |
| Individualized | subclass of | Algo |
| The Cure | author | Robert Pattinson |
| Personalized Treatments | subclass of | Treatments |
| Personalized Treatments | subclass of | Treatment |
| Treatments | medical condition treated | Epilepsy |
| Gene | part of | Neural Circuits |
| Gene | encodes | Protein |
| Gene | part of | Brain |
| Neural Circuits | studied by | Researchers |
| Neural Circuits | use | Interrogation |
| Neural Circuits | has effect | Brain Disease |
| The Wasp Factory | cast member | John Cameron Mitchell |
| The Wasp Factory | author | John F. Kennedy |
| Clinicians | field of this occupation | Patients |
| Clinicians | has part | Researchers |
| Challenge Of The Past | subclass of | Challenge |
| Therapeutic Options | facet of | Epilepsy |
| Therapeutic Options | subclass of | Therapeutic |
| The Need For Novel Treatment Approaches To Address Drug-Resistant Epilepsy | main subject | Epilepsy |
| Innovative Treatment Approaches | subclass of | Treatment |
| Research | has part | Clinical |
| Research | subclass of | Treatment |
| Research | has part | Technological Advancements |
| Research | has part | Innovation |
| Research | has part | Studies |
| Specific Epilepsy | subclass of | Epilepsy |
| Specific Epilepsy | subclass of | Adjunctive Therapy |
| Non-Pharmacological Interventions | subclass of | Drug Targets |
| Frontiers In Neurology 01 | point in time | 01 |
| The Emergence Of New | facet of | New |
| Systematic Review | subclass of | Systematic |
| Systematic Review | subclass of | Overview |
| Systematic | subclass of | Scoping |
| Therapeutic Strategies | subclass of | Innovative |
| Therapeutic Strategies | subclass of | Strategies |
| Non-Invasive | subclass of | Biomarkers |
| Non-Invasive | subclass of | Biomarker |
| Biomarkers | facet of | Epilepsy |
| Biomarkers | part of | Environmental |
| Biomarkers | subclass of | Biomarker |
| Biomarkers | has part | Biomarkers |
| Biomarkers | subclass of | Markers |
| Biomarkers | use | Accuracy |
| Neurostimulation | subclass of | Device |
| Neurostimulation | has part | Electrical Im- |
| Neurostimulation | subclass of | Significant |
| Neurostimulation | has effect | Neurostimulation |
| Neurostimulation | different from | Overstimulation |
| Neurostimulation | subclass of | Responsive Neurostimulation |
| Neurostimulation | instance of | Therapies |
| Neurostimulation | subclass of | Pharmacological Treatments |
| Neurostimulation | has part | Neuromodulation |
| Neurostimulation | part of | Rns System Pivotal Trial |
| Device | number of participants | 33 |
| Pediatric | subclass of | Patients |
| Pediatric | subclass of | Pediatric |
| Pediatric | subclass of | Data |
| Pediatric | subclass of | Studies |
| Pediatric | subclass of | Epilepsy |
| Pediatric | instance of | Age |
| Pediatric | subclass of | Ies |
| Pediatric | subclass of | Sd |
| Pediatric | instance of | 3 Y9 |
| Pediatric | number of participants | 9 |
| Pediatric | instance of | Y69 |
| Pediatric | instance of | Population |
| Pediatric | instance of | Age Ranges |
| Pediatric | opposite of | Adult |
| Pediatric | different from | Hospital |
| Rns | subclass of | Neurostimulation Device |
| Rns | part of | Rns System |
| Rns | instance of | Algorithm |
| Rns | instance of | Sys |
| Rns | different from | Rns |
| Rns | medical condition treated | Epilepsy |
| Figure 1 | depicts | Asms |
| Figure 1 | depicts | Figure |
| Thomas Hebdon | child | Megan |
| Thomas Hebdon | occupation | M |
| Precision Medicine | subclass of | Advancements In Precision Medicine |
| Precision Medicine | studies | Mental Factors |
| Precision Medicine | uses | Precision |
| Avery | member of sports team | Bodden 5 |
| 2 | followed by | 6 |
| 2 | said to be the same as | 117 |
| Yingchao | ranking | Yuan 5 |
| Clifford | sibling | Calley |
| Calley | sibling | Clifford |
| Genetic | has part | Profiles |
| Genetic | subclass of | Treatments |
| Profiles | part of | Genetic |
| Genetic Epilepsy | subclass of | Syndromes |
| Genetic Epilepsy | subclass of | Epilepsy |
| 2021 | point in time | 2021 |
| Baylor College Of Medicine | located in the administrative territorial entity country | Houston United States |
| Houston | country | United States |
| United States | contains administrative territorial entity | Tx |
| Tx | country | United States |
| University Of Texas School Of Nursing | located in the administrative territorial entity | Austin |
| Austin | located in the administrative territorial entity | Austin |
| Dbs | subclass of | Neurostimulation Device |
| Dbs | subclass of | Neuromodulation |
| Unresponsive | subclass of | Asms |
| University Of Utah College Of Nursing | located in the administrative territorial entity | Salt Lake City |
| University Of Texas | headquarters location | Austin, Tx |
| Pe Rsonalized Approaches | subclass of | Precision Medicine |
| University Of Texas At Austin Dell Medical School | located in the administrative territorial entity | Austin, Tx |
| Molecular | part of | Genetic |
| Molecular | studied by | Chemistry |
| 6Barry University | located in the administrative territorial entity | St. |
| Therapies Used In The Management Of Epilepsy | facet of | Epilepsy |
| Surgical Interventions | has part | Dietary Changes |
| Innovati Ve Therapies | facet of | Epilepsy Management |
| Refractory Epilepsy | subclass of | Seizure |
| Refractory Epilepsy | instance of | Risk Factor |
| Refractory Epilepsy | subclass of | Epilepsy |
| Neurostimulator | subclass of | Implanted |
| Neurostimulator | subclass of | Implantable |
| Sudep | subclass of | Sudden Unexpected Death In Epilepsy |
| Sudep | subclass of | Deaths Within This Group |
| Sudep | subclass of | Epilepsy |
| Sudden Unexpected Death In Epilepsy | facet of | Epilepsy |
| On -Demand Electrical Stimulation | medical condition treated | Seizure |
| John F. Kennedy School Of Government | part of | Harvard University |
| Vagus Nerve | part of | Brain Acti Vity |
| Vagus Nerve | connects with | Vagus Nerve |
| Vagus Nerve | uses | Electrical Impulses |
| Vagus Nerve | instance of | Nerve |
| Vagus Nerve | use | Stimulation |
| Vagus Nerve | part of | Neuronal Activity |
| Vagus Nerve | has part | Afferent Fibers |
| Vagus Nerve | has part | Afferent |
| Detection System | facet of | Seizure |
| Systems | has part | Devices |
| Neuromodulation | subclass of | Modulation Of Neural Activity |
| Neuromodulation | has effect | Dbs |
| Neuromodulation | subclass of | Pharmacological Interventions |
| Neuromodulation | subclass of | Seizure Prediction |
| Neuromodulation | medical condition treated | Drug-Resistant Epilepsy |
| Neuromodulation | point in time | 2022 |
| Neuromodulation | subclass of | Stimulation |
| Crd42024444250 | instance of | Systematic Review |
| Neural Activity | part of | Brain |
| Environmental Biomarkers | subclass of | Physiologic |
| Physiologic | part of | Environ |
| Physiologic | has part | Environmental |
| Cannabis Plant | has part | Cannabidiol |
| Cannabis Plant | subject has role | Anticonvulsant |
| Anticonvulsant | subclass of | Properties |
| Anticonvulsant | subclass of | Therapeutic |
| Anticonvulsant | subclass of | Antacid |
| Anticonvulsant | subclass of | Effects |
| Cinahl Ultimate | has part | Web Of Science |
| Cinahl Ultimate | has part | Embase |
| Web Of Science | instance of | Electronic Database |
| Web Of Science | part of | Pubmed |
| Prop Erties | subclass of | Anticonvulsant |
| Frequency | subclass of | Seizure |
| Frequency | subclass of | Pulse Width |
| Two-Step Process | subclass of | Investigator |
| Data Extraction | subclass of | Extract |
| The Limitations Of Traditional Therapies | facet of | Traditional Therapies |
| Patient Char | subclass of | Extractors |
| Forecasting | part of | Statistics |
| Forecasting | subclass of | Results |
| Forecasting | subclass of | Accuracy |
| Forecasting | subclass of | Forecasting |
| Forecasting | has part | Accuracies |
| Forecasting | facet of | Patient-Specific |
| Forecasting | uses | Rithm |
| Forecasting | studies | Seizure |
| Statistics | number of participants | 21 |
| Li Ving | has effect | Epilepsy |
| Evidence Quality | used by | Inves |
| Grading Of Recommendations, Assessment, Development | facet of | Igator |
| Grade | use | Evaluation |
| Grade | facet of | Reliability |
| Grade | use | Certainty In Evidence |
| Evaluation | part of | Development |
| Drug-R Esistant Epilepsy | subclass of | Adaptive Treatment |
| Adaptive Treatment | subclass of | Personalized |
| Cohort Studies | subclass of | Observational |
| Cohort Studies | subclass of | Studies |
| Observational | instance of | Grade |
| Rns System | instance of | Medical |
| Electrocardiogram | subclass of | Measurement |
| Electrocardiogram | subclass of | Continuous Electrocardiogram |
| Pre-Ictal Anticipation Algorithm | instance of | Algorithm |
| Algorithm | use | Responsiveness |
| Algorithm | studied by | Algorithm Study |
| Algorithm | studies | Analyzed A Sample |
| Algorithm | subclass of | Algorithm |
| Intracranial | part of | Brain Region |
| Seizure Initiation | has effect | Seizure |
| Seizure Initiation | location | Region |
| 8 S | followed by | 32 Min |
| 32 Min | follows | 8 S |
| 32 Min | said to be the same as | 80 S |
| Fundamental | part of | System |
| System | subclass of | System |
| System | use | Tion |
| Biomarker | facet of | Cardiovascular |
| Biomarker | subclass of | Algorithm |
| Biomarker | subclass of | Predictive Factors |
| Biomarker | subclass of | Study |
| Biomarker | subclass of | Measurement |
| Biomarker | instance of | Study Type |
| Biomarker | subclass of | Physiological |
| Biomarker | subclass of | Changes |
| Biomarker | subclass of | Biomarker |
| Biomarker | subclass of | Changes In Segments |
| Biomarker | has effect | Benefit |
| Mo Nitor | subclass of | Brain Activity |
| Brain Activity | part of | Brain |
| Brain Activity | subclass of | Continuously Monitors Brain Activity |
| Brain Activity | part of | Real-Time |
| Brain Activity | part of | Patient’S Brain |
| 40 Min | length | 59 |
| Stimulat | subclass of | Ion |
| Monitoring Brain Activity | part of | Rns |
| Seizure Forecasting | facet of | Seizure |
| Seizure Forecasting | facet of | Epilepsy |
| Seizure Forecasting | subclass of | Forecasting |
| Seizure Forecasting | subclass of | Biomarker |
| Seizure Forecasting | subclass of | Algo |
| Seizure Forecasting | has part | Tive |
| Seizure Forecasting | subclass of | Algorithm |
| Seizure Forecasting | facet of | Patient |
| Onset Of A Seizure | subclass of | Subtle Changes |
| 9/11 | point in time | 9/11 |
| Low | instance of | Certainty |
| Low | subclass of | Erate |
| Low | instance of | Evidence Grading |
| Risk Of Bias | subclass of | Methodological Flaws |
| Methodological Flaws | facet of | Methodological |
| Detecting Seizure Onset | facet of | Seizure |
| Sparse Evidence | subclass of | Sparse Evidence |
| Sparse Evidence | subclass of | Bias |
| University Of Pennsylvania | located in the administrative territorial entity | Philadelphia |
| University Of Pennsylvania | subsidiary | School Of Medicine |
| The Figure | depicts | Figure |
| Responsive Neu- | subclass of | Neu |
| Prospero | instance of | Systematic Review Registration |
| Prospero | instance of | Preferred Reporting Items |
| Type Systematic Review | instance of | Systematic Review |
| On-Demand Electrical Stimulation | medical condition treated | Seizure Frequency |
| 2026 | point in time | 20 April 2026 |
| Hua-Jun Feng | family | Feng |
| Massachusetts General Hospital | located in the administrative territorial entity | Massachusetts |
| Modulate Brain Activity | has effect | Seizure Occurrences |
| Harvard Medical School | country | United States |
| Brain Regions | part of | Specific |
| Brain Regions | facet of | Seizure Generation |
| Jacopo Lanzone | family | Lanzone |
| Electrical Stimulation | has effect | Seizure Control |
| Electrical Stimulation | facet of | Electrical |
| San Raffaele Hospital | country | Italy |
| Masoud Hassanvand-Amouzadeh | family | Amouzadeh |
| Qom University Of Medical Sciences | located in the administrative territorial entity | Qom |
| Correspondence | has part | Correspondence |
| Clifford Calley | sport | Football |
| Innovative Treatment | subclass of | Treatments |
| Received 03 January 2026 | point in time | 03 January 2026 |
| Accepted 24 March 2026 | point in time | 24 March 2026 |
| M | has part | M |
| M | contains administrative territorial entity | Marzec |
| M | has part | Simonato |
| Agrawal R | member of political party | Do G |
| Intracranial Electrodes | part of | Brain |
| Dupree G | sibling | Rajotte J |
| Rajotte J | sibling | Dupree G |
| Region | different from | Country |
| Yuan Y And Calley C | instance of | Systematic |
| Closed-Loop Neurostimulation | subclass of | Brain Activity |
| Closed-Loop Neurostimulation | facet of | Ai |
| Electrical | part of | Neural Activity |
| 2026 Esparza, Thomas Hebdon | point in time | 2026 |
| Agrawal | sibling sibling | Wang Wang |
| Agrawal | award received | M |
| Rajotte | shares border with | Ciofuli |
| Ciofuli | shares border with | Rajotte |
| Open-Access | subclass of | Article |
| The Mistletoe | author | John F. Kennedy |
| Attribution License | author | Creative Commons |
| Onset | has effect | Seizure |
| Onset | part of | Focal |
| Distribution | subclass of | Use |
| Distribution | part of | Reproduction |
| Detection Algorithm | subclass of | Algorithm |
| Production | part of | Forums |
| Original | subclass of | Permitted |
| Permitted | different from | Comply |
| Responsive Stimulation | part of | System |
| Copyright Owner | subclass of | Author |
| Author | field of this occupation | Author |
| Epileptic | has effect | Seizure |
| Cited | part of | Journal |
| Firing | part of | Neural |
| Firing | subclass of | Synchronization |
| Neural | has effect | Epilepsy |
| Accepted Academic Practice | subclass of | Accepted Academic Practice |
| Adaptation And Learning | subclass of | Learning |
| Comply | different from | Permitted |
| Adapt | subclass of | Learn |
| Learn | has effect | Adapt |
| Tungusic Languages | subclass of | Chinese Language |
| Seizure Detection | subclass of | Algorithm |
| Seizure Detection | facet of | Epilepsy |
| Esparza Et Al | named after | Esparza |
| Stimulation | has effect | Side |
| Stimulation | has effect | Seizure |
| Stimulation | subclass of | Targeting |
| Stimulation | has part | Stimulation Site |
| Stimulation | subclass of | Stimulation |
| Frontiers In Neurology 02 | point in time | 02 |
| Keywords | instance of | Website |
| Pivotal | facet of | Clinical Trial |
| Clinical Trial | subclass of | Investigat |
| Clinical Trial | subclass of | Research |
| Clinical Trial | subclass of | Studies |
| Clinical Trial | facet of | System |
| Clinical Trial | uses | Evidence |
| Clinical Trial | subclass of | Clinical Trial |
| Clinical Trial | part of | Clinical |
| Clinical Trial | part of | Evidence-Based Use |
| Focal Epilepsy | drug used for treatment | Significant Benefits |
| Focal Epilepsy | subclass of | Drug-Resistant |
| Focal Epilepsy | drug used for treatment | Adjunctive Cenobamate |
| Partial | subclass of | Disabling |
| World Health Organization | inception | 2024 |
| Multiple Asms | subclass of | Onset Seizure |
| 2008 Summer Olympics | point in time | 2008 |
| 2008 | point in time | 2008 |
| Reduction | subclass of | Reduction |
| Antiseizure | medical condition treated | Epilepsy |
| Antiseizure | subclass of | Medication |
| One Year | followed by | Two Years |
| Refractory | subclass of | Medication |
| Refractory | subclass of | Epilepsy |
| Long-Term | has part | Follow-Up |
| Long-Term | facet of | Medication |
| Long-Term | facet of | Safety |
| Medical Management | facet of | Seizure |
| Initial Clinical Trial | instance of | Clinical Trial |
| Surgical | has part | Candidate |
| Evidence | facet of | Real-World |
| Evidence | subclass of | Evidence |
| Surgery | medical condition treated | Seizures |
| Family | has part | Patient |
| Zure Control | subclass of | Control |
| Control | facet of | Control |
| Pwe | located in the administrative territorial entity | Pwe |
| Pwe | subclass of | Caregivers |
| Pwe | instance of | Disease |
| Focal | subclass of | Seizure |
| Focal | subclass of | Significant Seizure |
| Focal | subclass of | Bilateral Tonic |
| Focal | drug used for treatment | Cenobamate |
| Premature Death | has cause | General Population |
| Resective Surgery | uses | Resective |
| Surgical Intervention | part of | Surgical |
| Drowning | has effect | Injuries |
| Potential Side Effects And Safety Considerations In Rns | published in | Rns |
| Safety Considerations | facet of | Safety |
| Adverse Events | has effect | Adverse Event |
| Characteristic | has effect | Seizure |
| Uncertainty Of Epilepsy | subclass of | Uncertainty |
| Surgical Risks | facet of | Surgical Procedure |
| Infection | subclass of | Risks Associated With Brain Surgery |
| Infection | subclass of | Hardware-Related Issues |
| Anesthesia-Related Complications | subclass of | Complications |
| Stigmatization | facet of | Lifestyle Restriction |
| Neurosurgical Techniques | part of | Neurosurgical |
| Reduced Quality Of Life | subclass of | Quality Of Life |
| Mifephing | drug used for treatment | Mifephing |
| Side | has part | Cbd |
| Caregivers | subclass of | Patients |
| Caregivers | field of this occupation | Children |
| Effects Of Rns | facet of | Rns |
| Psychological | has part | Physical |
| Mild Side Effect | subclass of | Side Effect |
| Tingling | has cause | Electrical Stimulation |
| Tingling | instance of | Effect |
| Recognition | part of | Cognition |
| Seizure-Related Incident | has cause | Seizure |
| Temporary | subclass of | Diminish Over Time |
| Brain Adapts To The Stimulation | subclass of | Stimulation |
| Treatment Options | medical condition treated | Epilepsy |
| Treatment Options | subclass of | Treatment |
| Hardware | used by | Software |
| Isolation | has part | Frustration |
| Population | has part | Factors |
| Population | has part | Population Size |
| Population | has part | Patient |
| Population | subclass of | Population |
| Population | studied by | Population Being Studied |
| Monitoring | subclass of | Maintenance |
| Monitoring | subclass of | Monitoring |
| Monitoring | subclass of | Monitor |
| Battery Replacement | part of | System |
| Psioc | connects with | Cervical Cord |
| Cervical Cord | connects with | Psioc |
| Pat | subclass of | Unrecognized |
| Seizure Onset | subclass of | Medical Management |
| Seizure Onset | has effect | Seizure |
| Seizure Onset | subclass of | Prepare For Seizure |
| Memory | part of | Cognitive |
| Cognitive Side Effect | subclass of | Mild |
| Changes | has effect | Hr |
| Epiglottis | part of | Epiglottis |
| Effects | facet of | Effect |
| Community | facet of | Lepsy |
| Stimulation Parameters | part of | Stimulation |
| Stimulation Parameters | facet of | Seizure |
| High | subclass of | Seizure |
| High | instance of | Feeling |
| Scalp | medical condition treated | Epilepsy |
| Scalp | subclass of | Eeg |
| Adaptive | subclass of | Personalized |
| Eeg | part of | Intracranial |
| Seizure Prediction | subclass of | Eeg |
| Seizure Prediction | subclass of | Prevention |
| Seizure Prediction | subclass of | Algorithm |
| Seizure Prediction | subclass of | Sensitivity |
| Seizure Prediction | facet of | Epileptic |
| Challenging | subclass of | Challenging |
| Challenging | number of participants | 215 |
| Challenging | facet of | Humans |
| Forecasting Device | use | Forecasting |
| Side Effects | facet of | Safety Con |
| Minimally Invasive | subclass of | Minimally Invasive |
| Daily Living | subclass of | Activities |
| Measurable | subclass of | Biomarker |
| Management Options | number of participants | 57 |
| Predictive | has effect | Seizure |
| Device Implantation | part of | Surgical |
| In Pedi | facet of | Pedi |
| Pedi | uses | Pedi |
| Environmental | subclass of | Environment |
| Invasive | subclass of | Procedures |
| Potential Benefits | facet of | Constraint |
| Protocol | facet of | Systematic Review |
| Alternative Treatment | subclass of | Alternative Treatment |
| Prisma | has part | Systematic Review And Meta-Analyses |
| Guidelines | instance of | Guidelines |
| Heart | part of | Digestive System |
| School Of Medicine | parent organization | University Of Pennsylvania |
| Vns System | has part | Generator |
| Figure 2 | depicts | Figure |
| Left Vagus Nerve | part of | Neck |
| Interconnected Processes | has part | Interconnected |
| Search Criteria | use | Search |
| Regulation | facet of | Bodily Functions |
| Neuronal Activity | has part | Energy Availability |
| Mesh | medical condition treated | Epilepsy |
| Intermittent | subclass of | Electrical Stimulation |
| Pre-Defined Parameters | facet of | Vagus Nerve |
| Algorithms | has part | Seizures |
| 1990 | point in time | 1990 |
| Replicated | subclass of | Search Strategy |
| 1990–2023 | point in time | 1990 |
| Adjunctive Therapy | medical condition treated | Partial-Onset Seizures |
| Adjunctive Therapy | subclass of | Therapy |
| Adjunctive Therapy | facet of | Epilepsy |
| Clinical Studies | studies | Vns |
| 1990S | point in time | 1990 |
| Database | subclass of | Database |
| Occurrence | has effect | Seizure |
| Covidence | inception | 2023 |
| Covidence | instance of | Manually |
| Abstract Screening | followed by | Full-Text Screening |
| Full-Text Screening | uses | Full-Text |
| Long-Term Treatment | subclass of | Treatment |
| After Dupli | follows | Dupli |
| Dupli | followed by | After Dupli |
| Cates | instance of | Cates |
| Vns Technology | product or material produced | Vns |
| Eligibility Crite | subclass of | Reviewers |
| Independent Reviewers | uses | Abstract |
| Eligibility Criteria | has part | Include Or Exclude |
| Eligibility Criteria | subclass of | Eligibility Criteria |
| Cern | country | Switzerland |
| On-Demand Vns | subclass of | Closed-Loop |
| Closed-Loop | subclass of | Systems |
| Closed-Loop | use | Epilepsy Management |
| Closed-Loop | subclass of | Algorithm |
| Closed-Loop | part of | Vagus Nerve |
| The New York University | located in the administrative territorial entity | New York City |
| Vns Stimu | facet of | Seizure Activity |
| Seizure Activity | subclass of | Significant |
| Seizure Activity | subclass of | Tion |
| Seizure Activity | has effect | Seizure |
| Seizure Activity | has cause | Hr Changes |
| Seizure Activity | has cause | Meteorological Factors |
| Seizure Activity | subclass of | Processes Underlying Seizure |
| Seizure Activity | subclass of | Confirmed |
| Conflict | subclass of | Conflict |
| Abnormal Brain Activity | has effect | Lation |
| Disagreements | subclass of | Disagreements |
| Spcifically | facet of | Seizure |
| Unoriginal Research Studies | subclass of | Research Studies |
| Device Design | product or material produced | Device |
| Review | uses | Rele |
| Review | uses | Conclusion |
| Review | facet of | Authors |
| Stimulation Parame | use | Stimulation |
| Vant Publication | subclass of | Publication |
| Publication | facet of | Publication |
| The Best Supporting Actor In A Drama Series | instance of | Academy Award |
| Acc | has part | Accelerometer |
| Acc | instance of | Biomarkers |
| Accelerometer | part of | Acc |
| Sponse | number of episodes | 79 |
| Ecg | subclass of | Electrocardiogram |
| Ecg | has part | Features |
| Ecg | part of | Upper Envelope |
| Ecg | subclass of | Measures |
| Patient-Centric | subclass of | Customization |
| Fd | subclass of | Fractal Dimension |
| Fd | has effect | Increased |
| Fd | subsidiary | Hr |
| Fractal Dimension | part of | R-To-R Interval |
| Hr | subclass of | Heart Rate |
| Hr | parent organization | Rri |
| Hr | facet of | Hr |
| Hr | different from | Standard Deviation Of Rri |
| Hr | has part | Hrv |
| Hr | different from | Temp |
| Hr | has part | Changes In Hr |
| Hr | has cause | Changes |
| Hr | subclass of | Normal |
| Hr | instance of | Trends In Hr |
| Heart Rate | part of | Ecg |
| Heart Rate | subclass of | Anomaly Detection Of Heart Rate |
| Heart Rate | subclass of | Seizure Prediction |
| Rechargeable | subclass of | Vns |
| Hrstd | instance of | Standard Deviation |
| Battery Replacement Surgery | subclass of | Replacement |
| Lfnorm | subclass of | Normalized Low-Frequency |
| Recharge | has effect | Recharged |
| Surgical Procedures | has effect | Burden |
| Rri | subclass of | R-To-R Interval |
| Rri | part of | Hr |
| Rri | part of | Population |
| Rri | instance of | Surrogate Data Marker |
| Temperature | facet of | Temperature |
| Temperature | part of | Meteorological Factors |
| Frontiers In Neurology 03 | point in time | 03 |
| Reference Checking | subclass of | Studies |
| Studies | subclass of | Studies |
| Studies | has part | Analyses |
| Studies | studied by | Clinical |
| Studies | studies | Clinical Translation |
| Uncontrolled Seizures | subclass of | Pediatric |
| Childhood Epilepsy Syndrome | subclass of | Severe |
| Drop Attacks | subclass of | Seizure |
| Synthesis | subclass of | Manually Extracted |
| The Missing Evidence | author | John F. Kennedy |
| Lgs | instance of | Types Characteristic Of Lgs |
| Co-Investigator | subclass of | Independent |
| Co-Investigators | subclass of | Co-Investigator |
| Responsiveness | facet of | Responsibility |
| Mixed | instance of | Mixed |
| Mixed | subclass of | Quantification Analysis |
| Adults | different from | Children |
| Children | different from | Adults |
| Vns Therapy | subclass of | Traditional Vns Therapy |
| Synergistic | subclass of | Synergistic |
| Data | has part | Specific Data |
| Data Items | part of | Data |
| Data Items | part of | Category |
| Specific Asms | use | Neuromodulation |
| Meta-Analyses | facet of | Systematic Reviews |
| Number Of Articles | instance of | Chart |
| Trials | use | Therapeutic |
| Trials | part of | Studies |
| Duplicate | subclass of | Duplicate |
| Full-Text Studies | subclass of | Abstracts |
| Studies Remained For Inclusion | subclass of | Inclusion |
| Number Of Studies | facet of | Exclusion Decisions |
| 2010 Commonwealth Games | point in time | 2010 |
| 2010 | point in time | 2010 |
| Frontiers In Neurology 04 | point in time | 04 |
| Patient Characteristics | subclass of | Study Characteristics |
| Medical Condition Treated | subclass of | Medication |
| Adverse Effect | facet of | Medical Intervention |
| Mean Age | instance of | Age Range |
| Age Range | facet of | Unspecified |
| Age Range | different from | Mean |
| Modulation | uses | Electrical Impulses |
| Modulation | subclass of | Biosignal |
| Study | subclass of | Rating |
| Study | facet of | Patients |
| Predictive Models | use | Predictive |
| Epileptic Seizure | has effect | Ameliorating |
| Epileptic Seizure | subclass of | Setting |
| Epileptic Seizure | has cause | Increased Incidence |
| Epileptic Seizure | has cause | Epilepsy |
| Epileptic Seizure | has part | Pediatric |
| Epileptic Seizure | subclass of | Epileptic Seizure |
| Epileptic Seizure | has cause | Environmental Factors |
| Neural Interaction | has effect | Neural Interaction |
| Neural Interaction | has effect | Physiological Consequences |
| Evidence Grade | facet of | Evidence |
| Unintended Repercussions | facet of | Unintended |
| Grading | use | Data Extraction |
| Development | subclass of | Development |
| Afferent Fibers | part of | Vagus Nerve |
| Peripheral Tissues | part of | Cns |
| Initial Rating | facet of | Independent Investigators |
| Adverse Outcomes | subclass of | Outcomes |
| Vagus | connects with | Vocal Cord |
| Meta-Analysis | facet of | Meta-Analysis |
| Meta-Analysis | part of | Systematic Review |
| Meta-Analysis | part of | Controlled Trial Review |
| Vocal Cords | has part | Stimulation |
| Methodological | has part | Statistical Heterogeneity |
| Stridor | subclass of | Hoarseness |
| Mod | subclass of | Continuum |
| Spasm | subclass of | Involuntary |
| Laryngeal Muscles | has effect | Respiratory Difficulties |
| Randomized Controlled Trial | uses | Automatic High Rating |
| Randomized Controlled Trial | subclass of | Studies |
| Evidence Rating | subclass of | Algorithm |
| 21 | point in time | 21 |
| 21 | followed by | 50 Years |
| 21 | opposite of | 7 Min |
| 21 | number of participants | 3 |
| Cough | drug used for treatment | Reflex |
| Reflex | medical condition treated | Cough |
| High Rating | facet of | Well-Conducted |
| Severe Coughing Episodes | subclass of | Distressing |
| Bias | subclass of | Risk |
| Bias | subclass of | Inconsistencies |
| Risk | studied by | Evaluation |
| Dyspnea | has cause | Afferent Signaling |
| Moderate Cer | opposite of | Moderate Cer |
| Breathlessness | facet of | Breathing |
| This Respiratory | subclass of | Respiratory |
| Lung Function | subclass of | Compromised |
| Indirect Evidence | subclass of | Bias |
| Vomiting | has effect | Nausea |
| Very Low Cer | subclass of | Cer |
| Well-Being | facet of | Mentally |
| Contradictory | facet of | Methodological Limitations |
| Regime | subclass of | Protocol |
| Sleep Apnea | subclass of | Sleep |
| Afferent | part of | Vagus Nerve |
| Brainstem | has part | Respiratory Centers |
| Breathing Patterns During Sleep | facet of | Sleep |
| Elevation | has cause | Disruption |
| Apnea-Hypopnea Index | facet of | Sleep Apnea |
| Shallow Breathing | subclass of | Pauses In Breathing |
| Size | part of | Population |
| The Complex | instance of | Complex |
| Age | different from | Mean Age |
| Age | part of | Sample |
| Age | subclass of | Seizures |
| Age | part of | Sample Size |
| Age | has part | Median |
| Age | instance of | Factors |
| Vagal Stimulation | subclass of | Neural Regulation |
| 18 | point in time | 18 |
| Adult | subclass of | Data |
| Adult | subclass of | Pediatric Epilepsy |
| One Study | instance of | Study |
| One Study | main subject | Rri |
| One Study | main subject | Seizures |
| Median | instance of | Measures |
| Median | is a list of | H |
| Measures | part of | Orological |
| Researchers | studies | Neural Circuits |
| Exclu | instance of | Exclu |
| Therapeutic Strategy | subclass of | Strategy |
| Pediatric-Specific Data | subclass of | Data |
| Pediatric-Specific Data | part of | Table 3 |
| Pediatric-Specific Data | subclass of | Pediatric-Specific Data |
| Brain Stimulation | medical condition treated | Epilepsy |
| Table 3 | facet of | Characteristics |
| Drug | medical condition treated | Epilepsy |
| Drug | used by | Patients |
| Stud | subclass of | Stud |
| Resistant Seizure | subclass of | Seizures |
| Movement Disorder | subclass of | Treatment |
| Represented | is a list of | Represented |
| Parkinson’S Disease | instance of | Therapeutic Option |
| Cohort Study | subclass of | Retrospective |
| Cohort Study | uses | Prospective |
| Retrospective | subclass of | Spective |
| Retrospective | subclass of | Retrospective |
| Retrospective | subclass of | Cohort Study |
| Uncontrolled | subclass of | Epilepsy |
| Sample Size | different from | Number Of Seizures |
| Sample Size | facet of | Forecasting |
| Sample Size | facet of | Surrogate Data |
| Sample Size | has effect | Effect |
| Period | number of episodes | 22 |
| Period | facet of | Seizure |
| 22 | point in time | 22 |
| 22 | followed by | 23 |
| 22 | followed by | 167 |
| 22 | number of participants | 16 |
| 22 | followed by | 237 |
| 22 | followed by | 55 |
| 0-10-Year-Old | instance of | Age Group |
| Dbs For Epilepsy | medical condition treated | Epilepsy |
| Characteristics | studied by | Meteorological |
| Forecasting Algorithm | subclass of | Algorithm |
| Forecasting Algorithm | use | Forecasting |
| Anterior Nucleus | part of | Thalamus |
| Anterior Nucleus | part of | Tha |
| Thalamus | has part | Anterior Nucleus |
| Thalamus | field of work | Functional Neurosurgery |
| Cerebral Cortex | has part | Ant |
| Ant | uses | Electrical Stimulation |
| Limbic System | has part | Ant |
| Retrospective Design | subclass of | Spective |
| Pediatric-Specific | subclass of | Study |
| Pediatric-Specific | subclass of | 1 Y |
| Pediatric-Specific | subclass of | Data |
| Pediatric-Specific | subclass of | Ecg |
| Pediatric-Specific | subclass of | Cohort |
| Analyzed | studies | Patients |
| 2007 | point in time | 2007 |
| Likelihood Of Seizures | facet of | Seizure |
| 24 H | number of episodes | 24 |
| Alternative Targets | subclass of | Targets |
| 27 | followed by | 30 |
| Cardiovas | studied by | Physiological |
| Subthalamic Nucleus | part of | Specific |
| Aretha Franklin | member of | The Beatles |
| Clinical Evidence Illustrating The Efficacy And Safety Of Dbs | main subject | Efficacy And Safety Of Dbs |
| Continuous Electrocardiogram | subclass of | Ecg |
| Empatica E4 | instance of | Biosensor |
| Empatica E4 | instance of | Wristband |
| Case Report | subclass of | Clinical Studies |
| Apen | subclass of | Entropy |
| Apen | instance of | Increased |
| Blood Volume Pulse | subclass of | Peripheral Body Temperature |
| Peripheral Body Temperature | subclass of | Temperature |
| Multicenter | subclass of | Randomized Controlled |
| Electrodermal Activity | has part | Accelerometer |
| Electrodermal Activity | part of | Electrodermal |
| Tha | has part | Anterior Nucleus |
| Accumu | instance of | Biomarkers |
| Relative Humidity | subclass of | Temperature |
| Relative Humidity | facet of | Wind Speed |
| Sham Stimulation | subclass of | Stimulation |
| 1-Year Follow-Up | number of participants | 1 |
| T-Cell | subclass of | Lymphocyte |
| Criteria | facet of | Inclusion |
| Non-Review | subclass of | Operational Definition |
| Sante Trial | instance of | Long-Term Follow-Up Studies |
| Frontiers In Neurology 05 | point in time | 05 |
| Correlational Study Details | facet of | Correlational |
| Liverpool Seizure | part of | First Year |
| Average | instance of | Study Type |
| Quality Of Life In Epilepsy | number of participants | 31 |
| 2000 Summer Olympics | point in time | 2000 |
| Statistically | studies | Improvements |
| Time Series | subclass of | Data |
| Mining | has part | Mining |
| Environmental Factors On Epileptic | facet of | Epileptic |
| Case Studies | subclass of | Real-World Experiences |
| Case Studies | has effect | Positive Impact |
| Seizures (2018) | instance of | Retrospective |
| Cohort | instance of | Study |
| Evidence Supporting Dbs Efficacy | facet of | Efficacy |
| Not Specified | part of | Not Specified |
| Precipitation | has part | Temperature |
| Seizure Semiolo | subclass of | Epilepsy |
| Gies | population | 117 |
| 117 | said to be the same as | 2 |
| Atmospheric Pressure | instance of | Max |
| Sunshine | has part | Atmospheric Pressure |
| Risks | has part | Benefits |
| Negatively | facet of | Ambient Temperature |
| Ambient Temperature | instance of | Correlated |
| Ambient Temperature | subclass of | Body Temperature |
| Ambient Temperature | has effect | Seizure Occurrence |
| Ambient Temperature | different from | Maximum Station |
| Well-Tolerated | subclass of | Safety |
| Max Atmospheric Pressure | facet of | Positively |
| Muscle Contraction | has effect | Sensation |
| Serious Complications | subclass of | Infrequent |
| 2022 | point in time | 2022 |
| 2022 | followed by | 2024 |
| 2022 | point in time | 2222 |
| 2022 | point in time | 22 |
| Closed-Loop Stimulation | subclass of | Stimulation |
| Closed-Loop Stimulation | subclass of | Device |
| Closed-Loop Stimulation | subclass of | Seizure Control |
| Closed-Loop Stimulation | part of | Medial Septum |
| University Of California, Berkeley | located in the administrative territorial entity | Berkeley, California |
| No-Seizure Group 9 | part of | No-Seizure Group 9 |
| Seizure Group 13 | number of participants | 13 |
| 13 | has part | E0204339 |
| Open-Loop Neurostimulation | subclass of | Neurostimulation |
| Focal Impaired | has part | Focal |
| Pre-Defined Intervals | subclass of | Electrical Impulses |
| Awareness Seizures | subclass of | Seizures |
| Generalized | subclass of | Generalized |
| Generalized | has part | Focal |
| Dynamic Adjust Stimulation | subclass of | Closed-Loop Systems |
| Closed-Loop Systems | use | Stimulation |
| Pre-Ictal Period | subclass of | Hrdecreased Hr |
| Pre-Ictal Period | instance of | Period |
| Pre-Ictal Period | followed by | Ictal Period |
| Pre-Ictal Period | subclass of | Seizure Activity |
| Pre-Ictal Period | instance of | Ecg Measurements |
| Pre-Ictal Period | follows | Pre-Ictal |
| Pre-Ictal Period | subclass of | Focal Seizure |
| Pre-Ictal Period | has part | Rri50 |
| Pre-Ictal Period | instance of | Entropy Calculation Of Eda |
| Pre-Ictal Period | follows | Interictal Period |
| Pre-Ictal Period | number of episodes | 23 |
| Pre-Ictal Period | instance of | Changes In The Pre-Ictal Period |
| Pre-Ictal Period | instance of | Baseline Hr |
| Pre-Ictal Period | instance of | Hr |
| Pre-Ictal Period | has part | One |
| Feedback | part of | Real-Time |
| Feedback | facet of | Long-Term Outcomes |
| Ictal Period | part of | Moderate |
| Ictal Period | follows | Pre-Ictal Period |
| Ictal Period | has part | Former |
| Electroencephalography | studies | Brain Signals |
| Novel Seizure Biomarkers | subclass of | Biomarker |
| Novel Seizure Biomarkers | part of | Electrocar |
| Pediatric Epilepsy Patients (2021) | point in time | 2021 |
| Physiological State | has part | Signs |
| Prodromal | subclass of | Pre-Seizure |
| 10 | area | 10 |
| 10 | instance of | Age |
| Detecting | subclass of | Detecting |
| 2 Y22 | facet of | Pediatric |
| Paediatric | subclass of | Medical |
| Progression | subclass of | Progression |
| Progression | facet of | Condition |
| Before They Fully Manifest | subclass of | Manifest |
| Apen68 | subclass of | Focal Seizures |
| Focal Seizures | drug used for treatment | Adjunctive Cenobamate |
| Psi-Med | located in the administrative territorial entity | Beijing |
| Psi-Med | parent organization | Medimmune |
| 40 | number of episodes | 40 |
| Overstimulation | different from | Neurostimulation |
| Studies And Trials Evaluating Closed-Loop Systems | subclass of | Trials Evaluating Closed-Loop Systems |
| Peri-Ictal Ecg Changes In Childhood | subclass of | Ecg |
| Implications For Detection | facet of | Epilepsy |
| Systems (2013) | genre | Retrospective |
| Resistant Epilepsy | subclass of | Epilepsy |
| Resistant Epilepsy | drug used for treatment | Ketogenic Diet |
| Relational9 | number of participants | 9 |
| Neuropace | instance of | Rns System |
| Focal Seizure | subclass of | Tle |
| Focal Seizure | subclass of | Impaired |
| Focal Seizure | subclass of | Pediatric |
| Focal Seizure | subclass of | Pre-Ictal Period |
| Focal Seizure | subclass of | Seizure |
| Tle | has part | Hrvhrv |
| Tle | subclass of | Temporal Lobe Epilepsy |
| Tle | number of participants | 27 |
| Tle | subclass of | Patients |
| Frontal Lobe | has part | Frontal Lobe |
| Generalized Seizures | subclass of | Seizures |
| Cervantes | country of citizenship | France |
| Tonic | followed by | Tonic–Clonic |
| Tonic–Clonic | subclass of | Seizure |
| Pre-Ictal Hr | subclass of | Hr |
| Pre-Ictal Hr | has part | Pre-Ictal Hr Increase |
| 3 | point in time | 3 |
| Specificity | opposite of | Sensitivity |
| Specificity | subclass of | Specificity |
| Sensitivity | subclass of | Sensitivity |
| Sensitivity | subclass of | Specificity |
| Sensitivity | has part | 51 |
| Sensitivity | subclass of | Accuracy |
| Sensitivity | subclass of | Mean Hr |
| Sensitivity | subclass of | Prediction Accuracy |
| Heart Rate Variability Analysis | subclass of | Analysis |
| Preictal Interval | instance of | Interval |
| Preictal Interval | studied by | Variability Analysis |
| Open-Loop | subclass of | Efficacy |
| Y | has part | Probability |
| Probability | opposite of | Chance |
| Longitudinal | followed by | Shortitudinal |
| Personalized Closed-Loop Approaches | facet of | Personalized Closed-Loop Approaches |
| Hrvhrv | part of | Tle |
| University Of Oxford | country | United Kingdom |
| Variations | facet of | Epilepsy |
| Variations | subclass of | Variations |
| St. Luke'S Hospital | located in the administrative territorial entity | London |
| Triggers | has effect | Seizure |
| 2012 Asian Games | point in time | 2012 |
| 2012 | point in time | 2012 |
| Closed-Loop System | subclass of | Inherent |
| Nex-1 | manufacturer | Cern |
| Heart Period Variability | subclass of | Monitoring |
| Personalized Treatment | subclass of | Strategies |
| Seizures Ii | subclass of | Seizures |
| Harnessing The Power | facet of | Patient-Specific |
| Ecog | subclass of | Eeg |
| Relational24 | number of participants | 24 |
| 2012 Summer Olympics | point in time | 2012 |
| Complex Partial | subclass of | Uncertaincomplex |
| Tachycardia | subclass of | Pre-Ictal |
| Pre-Ictal | followed by | Ictal |
| Pre-Ictal | subclass of | Seizure |
| Pre-Ictal | opposite of | Post-Ictal |
| Pre-Ictal | followed by | Pre-Ictal |
| Pre-Ictal | opposite of | Interictal |
| Pre-Ictal | instance of | Phase |
| Pre-Ictal | subclass of | Fea |
| Pre-Ictal | subclass of | Hr Changes |
| Data Analytics | subclass of | Technology |
| Autonomic Nervous System | part of | Nervous System |
| Autonomic Nervous System | has part | Pathetic Branch |
| Autonomic Nervous System | has effect | Autonomic Nervous System Imbalance |
| Nervous System | has part | Autonomic Nervous System |
| Nervous System | has part has part | Sympathetic Parasympathetic |
| Loop | part of | Complex |
| Peripheral Sensors | subclass of | Sensor |
| Peripheral Sensors | part of | Autonomic Nervous System |
| Sensor | studied by | Machine Learning |
| Effective Stimulation Parameters | facet of | Patient Population |
| Y66 | number of participants | 62 |
| Hrpre-Ictal Eda Signal Entropy | subclass of | Eda |
| Eda | subclass of | Entropy |
| Eda | instance of | Biomarkers |
| Eda | instance of | Physiological Mea |
| Eda | part of | Activation |
| Eda | facet of | Eda |
| Data Processing | part of | Systems |
| Very Low | subclass of | Low |
| The Lost Boys | cast member | John Wayne |
| Temporal Lobe Epilepsy | subclass of | Tle |
| Temporal Lobe Epilepsy | subclass of | Pre-Ictally |
| Temporal Lobe Epilepsy | medical condition treated | Medial Septum |
| Temporal Lobe Epilepsy | subclass of | Epilepsy |
| Cannabis Sativa | has part | Cannabidiol |
| Frontiers In Neurology 06 | point in time | 06 |
| Hemp | said to be the same as | Marijuana |
| Marijuana | said to be the same as | Hemp |
| Algorithm Study | studies | Algorithm |
| Tetrahydrocannabinol | different from | Another |
| Tetrahydrocannabinol | has part | Thc |
| Another | different from | Tetrahydrocannabinol |
| Psychoactive Effects | different from | Cannabinoid |
| Studies Evidence | facet of | Evidence |
| Focal Epileptic Seizure | subclass of | Anticipation |
| Anticipation | has effect | Focal Epileptic Seizure |
| Anticipation | part of | Signifi |
| Anticipation | subclass of | Anticipation |
| Patterns Of Heart Rate | facet of | Heart Rate |
| 2019 | point in time | 2019 |
| 2019 | number of episodes | 26 |
| Potential Pathways | subclass of | Pathway |
| Algorithm Testing | uses | Algorithm |
| Algorithm Testing | subclass of | Testing |
| Algorithm Testing | subclass of | Correlational |
| Endocannabinoid System | instance of | Signaling Network |
| Endocannabinoid System | has part | Endocannabinoid |
| Endocannabinoid System | studied by | Brain Sci |
| Neural Excitability | instance of | Physiological Processes |
| Hrvanticipation Accuracy | facet of | Seizure |
| 2011 World Championships | point in time | 2011 |
| 2011 | point in time | 2011 |
| 8 Svery Low | point in time | 8 |
| 8 | area | 8 |
| Influence | located in the administrative territorial entity | Cbd |
| Patient-Specific Seizure Prediction | subclass of | Patient-Specific Seizure Prediction |
| Patient-Specific Seizure Prediction | subclass of | Seizure Prediction |
| Transient Receptor Potential | subclass of | Non-Cannabinoid Receptor |
| Heart Rate Variability | has effect | Recurrence |
| Heart Rate Variability | facet of | Heart Rate |
| Heart Rate Variability | studied by | Recurrence Quantification Analysis |
| Neuroprotec | facet of | Pain Perception |
| Quantification Analysis | studies | Variability |
| Tion | number of episodes | 151 |
| Tion | number of episodes | 205 |
| Clinical Trials And Evidence Supporting The Use Of Cbd | main subject | Evidence Supporting The Use Of Cbd |
| Focal Impaired Awareness | subclass of | Impaired Awareness |
| Generalized Onset Motor | subclass of | Motor |
| Oral Solution | instance of | Pharmaceutical |
| Hrvexperiment 1 | facet of | Hrv |
| Hrvexperiment 1 | facet of | Hr |
| Hrv | facet of | Seizure |
| Hrv | has part | Mea |
| Hrv | subclass of | Changes |
| Hrv | part of | Hr |
| Hrv | subclass of | Cardiovascular Features Measured By Ecg |
| Hrv | subclass of | Features Derived From Hrv |
| Hrv | instance of | Biomarker |
| Hrv | subclass of | Features |
| Accuracy 88 | point in time | 88 |
| Effectiveness | has part | Safety |
| Sensitivity 89 | point in time | 89 |
| 89 | point in time | 89 |
| Lennox–Gastaut Syndrome | subclass of | Seizures |
| Lennox–Gastaut Syndrome | subclass of | Dravet Syndrome |
| False Positive Rate | subclass of | False Positive |
| False Positive | subclass of | False Positive |
| False Positive | subclass of | Rate |
| False Positive | subclass of | Probability |
| False Positive | subclass of | Experi |
| False Positive | facet of | Forecasting Device |
| False Positive | subclass of | Reported |
| Conventional Therapies | subclass of | Conventional Therapies |
| Experiment 2 | instance of | Experiment |
| Dravet Syndrome | drug used for treatment | Epidiolex ®In Dravet Syndrome |
| Accuracy 74 | point in time | 74 |
| Sensitivity 70 | point in time | 70 |
| Approval | facet of | Medication |
| Specificity 76 | point in time | 76 |
| 2009 World'S Fair | point in time | 2009 |
| 2009 | point in time | 2009 |
| False Positive Rate 3 | point in time | 3 |
| Anticipation Time 13 | point in time | 13 |
| Observational Studies | subclass of | Observational |
| Observational Studies | has part | Cer |
| 7 Minlow Certainty | instance of | Minlow Certainty |
| Wearable Epileptic Seizure Prediction | facet of | Epileptic Seizure |
| Machine-Learning | part of | System |
| Machine-Learning | use | Anomaly Detection |
| Different Degree Of Benefit | facet of | Benefit |
| Mechanism Of Action | facet of | Epilepsy |
| Cbd Perf Orms | subject has role | Inhibitory Role |
| Inhibitory Role | facet of | Faat |
| Awareness | said to be the same as | Aware |
| Aware | said to be the same as | Awareness |
| Trpv1 | has part has part | Cb1 Cb2 |
| Trpv1 | subclass of | Cb1 |
| Hrvsensitivity | subclass of | Ensitivity |
| Faah | has part | Andamide |
| Ca Nnabinoid Receptor | subclass of | Receptor |
| 1962/H | point in time | 1962 |
| Controls | different from | Healthy |
| Endocannabinoid | part of | Endocannabinoid System |
| Predicted Seizures Within 15 Min | subclass of | Seizures Within 15 Min |
| Cb1 | followed by | Cb2 |
| Cb1 | instance of | Lock And Key Mechanism |
| Cb1 | instance of | Greater |
| Cb1 | has part | Cannabinoid Receptor1 |
| Cb1 | instance of | Affinity |
| Cb2 | instance of | Lock And Key Mechanism |
| Cb2 | has part | Thc |
| Machine Learning | studies | Sensor |
| Machine Learning | studies | Sensor Data |
| Machine Learning | part of | Intelligence |
| Machine Learning | part of | Ai |
| Machine Learning | has part | Data Mining |
| Machine Learning | part of | Neuromorphic Architectures |
| Wearable | facet of | Seizure |
| Wearable | use | Seizure Forecasting |
| Wearable | has part | Sensor |
| Forecasting (2020) | number of participants | 32 |
| Thc | different from | Cb2 |
| Thc | part of | Tetrahydrocannabinol |
| Secondary Generalized | subclass of | Generalized |
| Bvp | member of | Acc |
| Bvp | has part | Tempa |
| Bvp | instance of | Biomarkers |
| Cannabinoid Receptor1 | part of | Cb1 |
| Chance | has effect | Tempaccuracy |
| Sensitivity 51 | point in time | 51 |
| Mean Prediction Horizon | subclass of | Horizon |
| Concerns And Considerations Regarding The Use Of Cbd | main subject | Cbd |
| Concerns | subclass of | Considerations |
| Cy Tochrome P450 Enzyme System | part of | Liver |
| Frontiers In Neurology 07 | point in time | 07 |
| Rela | has part | Station Pressure |
| Esse Ntial | instance of | Esse |
| Healthcare Providers | has part | Patients |
| One Of Two | subclass of | Two |
| Other Medications | subclass of | Medications |
| Some Individuals May | has part | Cbd |
| Dia Rrhea | subclass of | Fatigue |
| Transient | subclass of | Side Effect |
| Features | part of | Rithm |
| Country | different from | Region |
| Prescription Medication | has part | Cbd |
| Over-The-Counter | subclass of | Supplement |
| Standard Deviation Of Rri | different from | Hr |
| Upper Envelope | part of | Ecg Time Series |
| Hrv Features | part of | Mean |
| Hrv Features | instance of | Algorithm |
| High-Frequency Band | subclass of | Power |
| Re Alistic | subclass of | Monitor |
| Mea | part of | Hrv |
| Mea | subclass of | Ecg |
| Cbd Therapy | has part | Cbd |
| Baseline | subclass of | Threshold |
| Antici | has part | Antici |
| Continuous Use | subclass of | Prolonged |
| Pation Algorithm | number of participants | 77 |
| 2010 Fifa World Cup | point in time | 2010 |
| Titration | subclass of | Therapeutic |
| A Similar Study | instance of | Similar Study |
| Lennox–Ga Staut Syndrome | subclass of | Dravet Syndrome |
| Analyzed A Sample | studied by | Algorithm |
| Pediatric Seizure | subclass of | Seizure |
| Pediatric Seizure | subclass of | Zures |
| Anandamide | has part | Anandamide |
| Faah Inhibition | subclass of | Inhibition |
| Cannabinoid Receptor | part of | Human |
| Cannabinoid Receptor | part of | Cannabinoid |
| Rri50 | number of participants | 50 |
| Rri50 | medical condition treated | Tle |
| First Of Which | subclass of | Experiment |
| Lock | part of | System |
| The Flying Saucers | cast member | John Wayne |
| Patient-Specific Algo | subclass of | Algo |
| 7 Features Selected | is a list of | 7 Features Selected Per Patient |
| Second Experiment | has part | Six Patients |
| Six Patients | part of | Second Experiment |
| Three Or More Seizures | subclass of | Seizures |
| Test | facet of | Algorithm |
| Prediction Time | use | Prediction |
| Prediction | use | Prediction |
| Cytochrome P450 Enzyme System | part of | Liver |
| 28 | point in time | 28 |
| 28 | followed by | 31 |
| Healthcare | facet of | Patients |
| Applied Statistics In Machine | subclass of | Statistics |
| Iications | number of episodes | 5,156 |
| Appetite | has effect | Weight |
| 12/14 Sei | followed by | 14 |
| 157 | instance of | Gion |
| 158 | instance of | Gion |
| Pre-Ictal Interval | instance of | Interval |
| Empatica | instance of | Algorithm |
| Wrist-Watch | subclass of | Watch |
| Temp | part of | Eda |
| Temp | instance of | Biomarkers |
| Temp | different from | Hr |
| Accuracy | subclass of | Accuracy |
| Chance In 43 | number of participants | 43 |
| 1844 | point in time | 1844 |
| 80 S | said to be the same as | 32 Min |
| Psa | instance of | Performance Metric |
| Training Dataset | subclass of | Dataset |
| Prediction Algorithm | subclass of | Algorithm |
| Combination | subclass of | Biomarkers |
| Similar Profile | subclass of | Biomarkers |
| Periods | number of episodes | 23 |
| 23 | point in time | 23 |
| 23 | follows | 22 |
| 23 | number of participants | 6 |
| 23 | followed by | 24 |
| 23 | followed by | 26 |
| Amplitude | part of | Eda |
| Former | part of | Ictal Period |
| Prospective | subclass of | Observational |
| Potential Drug | subclass of | Concerns And Considerations |
| Emerging Therapeutic Avenues | inception | 2017 |
| 2017 | point in time | 1427 |
| 2017 | point in time | 2017 |
| 2017 | followed by | 18 |
| Interictal | followed by | Pre-Ictal Period |
| Interictal | followed by | Pre-Ictal |
| Significant | subclass of | Statistically Insignificant |
| Cenobamate | subject has role | Drug-Resistant |
| Cenobamate | instance of | New Drug |
| Cenobamate | subject has role | Sodium Channel Inhibitor |
| Hrv Measure | part of | Bio |
| One That Ana | instance of | Correlational Studies |
| Efficacy Profile | has part | Cenobamate |
| Seizure Freedom | has effect | Seizure |
| Clustering | part of | Algorithm |
| Voltage-Gated | subclass of | Mechanism Of Action |
| Positive Rate | instance of | Rate |
| Armamentarium | part of | Asms |
| Hrv Accuracy 77 | facet of | Heart Rate Variability Parameters (2019) |
| Evolving Landscape Of Epilepsy Treatment | facet of | Epilepsy |
| Anticipation Time | facet of | Anticipation |
| Fasting | subclass of | Metabolic State |
| Fasting | subclass of | Beneficial |
| Keto | uses | Keto |
| Carbohydrates | subclass of | Energy |
| Primary Fuel Source | subclass of | Fuel |
| Ketone Bodies | subclass of | Production |
| Ketone Bodies | has effect | Efficacy |
| Experiment 1 | number of participants | 7 |
| 7 | followed by | 559 |
| Wearable Epileptic Seizure Prediction System | facet of | Epileptic Seizure |
| Hrv Sensitivity | subclass of | Rate Variability |
| Within 15 Min | instance of | 0 |
| 0 | subclass of | S |
| 0 | instance of | Age |
| Fat | instance of | Specific |
| Fat | use | Caloric Intake |
| Protein | subject has role | Nutritional Balance |
| Protein | has part | Carbohydrate |
| Protein | has part | Carbohydrates |
| Protein | instance of | Ratio |
| Sensor Data | studied by | Machine Learning |
| 5% | area | 5 |
| Non-Pharmacological | facet of | Epilepsy |
| Mean Prediction | subclass of | Prediction |
| Mean Prediction | subclass of | Sample Size |
| Ketogenic | facet of | Ketogenic |
| Ketogenic | has part | Ketogenic Diet |
| Complete Seizure Freedom | subclass of | Seizure |
| Diet | has effect | Response |
| Diet | has part | Customizing |
| Frontiers In Neurology 08 | point in time | 08 |
| Neurodevelopmental | part of | Neurological |
| Neurodevelopmental | part of | Paediatric |
| Brain-Tumor-Related Epilepsy | subclass of | Disorders |
| Disorders | subclass of | Disorder |
| Rrimax | part of part of part of part of | Rri Rri Rri Rri |
| Rrimin | part of part of part of | Rri Rri Rri |
| Rrimean | part of part of part of | Rri Rri Rri |
| Potential Mechanisms Of Action And Variations Of The Ketogenic Diet | main subject | Ketogenic Diet |
| Lf | instance of | Measures |
| Lf | opposite of | Hf |
| Nonlinear Recurrence Quantification Analysis | has part | Rri50 |
| Hypothesis | subclass of | Hypothesis |
| Pre-Ictal Window | subclass of | Window |
| Neuronal | part of | Brain |
| Neuronal | studied by | Optogenetics |
| Neurotransmitter | part of | Brain |
| Nonseizure | subclass of | Seizure |
| Excitatory Neurotransmitter | opposite of | Inhibitory |
| Inhibitory | opposite of | Excitatory Neurotransmitter |
| Inhibitory | instance of | Cell Type |
| Nonseizure Seg | opposite of | Seizure |
| Better Seizure | subclass of | Seizure Activity |
| P < 0 | has part | M |
| Energy Metabolism | has effect | Significant |
| Energy Metabolism | location | Brain |
| Adenosine Triphosphate | instance of | Energy Currency |
| Cells | part of | Cell |
| Cells | has part | Genetic Material |
| Peri- | instance of | Peri- |
| Seizure Suppression | subclass of | Suppression |
| Classic Ketogenic Diet | instance of | 4:1 |
| Hr Changes | instance of | Biomarker |
| Hr Changes | facet of | Seizure Forecasting |
| Pre-Ictal Tachycardia | subclass of | Zures |
| Pre-Ictal Tachycardia | subclass of | Tachycardia |
| Pernod Ricard | country | France |
| Atkins Diet | instance of | Modified |
| Atkins Diet | opposite of | Ketogenic Diet |
| Low Glycemic Index Treatment | has part | Low Glycemic Index |
| Pre-Ictal Bradycardia | subclass of | Bradycardia |
| Bradycardia | subclass of | Tachycardia |
| 4:1 Ratio | said to be the same as | Classic 4:1 Ratio |
| 95% | number of participants | 25 |
| Taiwan | country | Taiwan |
| Dietary Preferences | part of | Lifestyle |
| Meteorological Factors | has part | Temperature |
| 31–40 | followed by | 41–50 Years |
| Cialis | part of | Cialis |
| 0–10 Years | instance of | Age Group |
| January | followed by | February |
| Geographic Regions | country | Taiwan |
| Maximum Atmo | subclass of | Maximum |
| Spheric Pressure | has effect | Seizure |
| Ketosis | part of | Metabolism |
| 12 Regions | country | Taiwan |
| 4 Discussion | number of participants | 4 |
| Biological | has part | Environmental |
| Mor | subclass of | Morbidity |
| Complementary Treatments | subclass of | Alternative |
| Study Purposes | facet of | Study |
| Better Quality Of Life | subclass of | Quality Of Life |
| Clinical Utility | facet of | Clinical |
| Gene Therapies For Epilepsy | medical condition treated | Epilepsy |
| Gene Therapy | subclass of | Innovative Approach |
| Gene Therapy | uses | Gene |
| Gene Therapy | medical condition treated | Epilepsy |
| Gene Therapy | subclass of | Therapies |
| Gene Therapy | instance of | Revolution |
| Gene Therapy | uses | Significant |
| Gene Therapy | instance of | Groundbreaking Approach |
| Gene Therapy | subclass of | Personalized |
| Gene Therapy | subclass of | Immunotherapy |
| Gene Therapy | genre | Novel |
| Gene Therapy | medical condition treated | Rare Genetic Diseases |
| Genetic Material | part of | Genetic |
| Fundamental Principle | subclass of | Principle |
| Hr/Rri | instance of | Biomarker |
| Electrodermal | part of | Electrodermal |
| Fore | has part | Fore |
| Genetic Abnormalities | has effect | Seizure |
| Disorder | has cause | Implicated |
| Cellular Function | has effect | Restore Normal Cellular Function |
| Targeted Epilepsy Treatments | subclass of | Novel |
| Gene Editing Technologies | part of | Field |
| Svalbard | country | Norway |
| Norway | contains administrative territorial entity | Svalbard |
| 26 | followed by | 28 |
| Crispr-Cas9 | use | Gene Editing |
| Gene Editing | uses | Gene |
| Gene Editing | subclass of | Tools |
| Gene Editing | subclass of | Techniques |
| Humboldt University | located in the administrative territorial entity | Humboldt, Germany |
| Sequences With Remarkable Accuracy | subclass of | Sequences |
| Sdrri | has part | Hr |
| Cas9 | part of | Crispr-Cas9 |
| Hfnorm | subclass of | Rri |
| Implicated | has effect | Disorder |
| Signaling Pathways | part of | Cellular |
| Epileptogenesis | has cause | Gene |
| Epileptogenesis | has cause | Specific |
| Disease-Causing Mutations | has effect | Correct |
| Seizure Forecasting Biomarkers | facet of | Seizure |
| Specific Genetic | subclass of | Gene Therapies |
| Defects | subclass of | Defects |
| A Longer Anticipation | subclass of | Anticipation |
| Safety And Efficacy Of Gene Therapies | instance of | Efficacy |
| Preclinical | subclass of | Development |
| Preclinical | part of | Research And Development |
| 7 Min | opposite of | 21 |
| Animal Model | subclass of | Studies In Animal Models |
| Animal Model | subclass of | Models |
| Animal Model | use | Gene Therapy |
| Animal Model | use | Optogenetics |
| Animal Model | uses | Neural Circuit |
| Animal Model | facet of | Epilepsy |
| Seizure 13 | instance of | Seizure |
| Preclinical Studies | subclass of | Therapeutic |
| Preclinical Studies | subclass of | Studies |
| Different Experiment | instance of | Biomarkers |
| Planning Stages | subclass of | Underway |
| Adeno-Associated Virus | subclass of | Vectors |
| Adeno-Associated Virus | instance of | Gene Therapy For Neurological Disease |
| Aav Vectors | use | Therapeutic |
| Lstm | has part | Lstm-2 |
| Lstm-2 | part of | Lstm |
| Important | subclass of | Importance |
| Complexity | subclass of | Complexity |
| False | instance of | False |
| 2 H | part of | 30 |
| Viral Vectors | subclass of | Delivery Methods |
| Unnecessary Disrup | subclass of | Clinical Utility |
| Efficient | subclass of | Gene Transfer |
| Immune Responses And Other Adverse Effects | subclass of | Adverse Effects |
| Off-Target Effects | subclass of | Gene Editing |
| Area Of Outstanding Natural Beauty | conferred by | National Trust |
| Ethical Considerations | facet of | Ethical |
| Genetic Modification | facet of | Informed Consent |
| One | instance of | One |
| One | part of | Pre-Ictal Period |
| Interictal Period | followed by | Pre-Ictal Period |
| Neurology | start time | 2000 |
| Conductance | part of | Skin |
| Genetic Anomalies | has effect | Seizure Disorders |
| Fight-Or-Flight | instance of | Physiological |
| Simultaneous Brady | subclass of | Brady |
| Activation | part of | Optogenetic |
| Molecular Mechanisms | facet of | Epileptogenesis |
| Sympathetic | part of | Nervous System |
| Parasympathetic | part of | Nervous System |
| Key Physiologi | subclass of | Biomarker |
| Genetic Forms | subclass of | Epilepsy |
| Inconsistent | subclass of | Inconsistent |
| Inconsistent | subclass of | Incompletely Reported |
| Car | part of | Car |
| Optogenetics In Epilepsy Research | facet of | Epilepsy |
| Prri50 | facet of | Fractal |
| Revolutionary Method | subclass of | Revolutionary |
| Rqa | field of work | Ent |
| Opsin | subclass of | Protein |
| Wavelengths Of Light | has part | Specific |
| Frontiers In Neurology 09 | point in time | 09 |
| Activated | subclass of | Opsin |
| Gen | has effect | Focal Seizure |
| Pre-Ictal Hr Changes | instance of | Hr Changes |
| Pre-Ictal Hr Changes | instance of | Utility |
| Selectively Activating | subclass of | Activating |
| Seizure Forecasting Mechanism | subclass of | Alarm |
| Effec | instance of | Biomarker |
| Network Synchronization | subclass of | Circuit Interaction |
| Beats Per Min | part of | Hr |
| Animal Models | facet of | Epilepsy |
| 1955 | point in time | 1955 |
| 1 Years | event distance | 1 |
| Regions | country | Taiwan |
| Optogenetically Stimulating | subclass of | Seizure Hotspots |
| Seizure Propagation | facet of | Epileptic Activity |
| Real Time | facet of | Real Time |
| Inhibiting These Regions | subclass of | Optogenetics |
| Brain Areas | part of | Development |
| 2% Of Patients Showed Changes | number of participants | 2 |
| Without | opposite of | Those Without |
| Those Without | opposite of | Without |
| Optogenetic | subclass of | Modulating Their |
| Optogenetic | has effect | Neurostimulation |
| Optogenetic | has part | Activation |
| Optogenetic | studies | Neural Circuitry |
| Suppress | has effect | Seizure |
| Brain Circuitry | facet of | Seizures |
| Recording | has effect | Manipulat |
| Electrocardiographic | subclass of | Changes Occur Frequently |
| Seizure Evolution | has part | Ictal |
| Eurekalert | owned by | Free Software Foundation |
| Interconnected Brain Regions | part of | Brain |
| High Level Of Incon | instance of | Incon |
| Epileptic Events | has cause | Abnormalities |
| Pre-Operative | subclass of | Pre-Doctor |
| Preclinical Research | has part | Optogenetics |
| Many With No Change | subclass of | Decreases |
| Significant Hurdles | facet of | Clinical Practice |
| Opto- | uses | Opto |
| Gene Delivery | part of | Genetics |
| Different Biomarkers | subclass of | Biomarker |
| Invasive Procedures | subclass of | Procedures |
| The Knowledge | subclass of | Knowledge |
| Meteorological | studies | Meteorological |
| Meteorological | studies | Characteristics |
| Targeted | subclass of | Effective Therapies |
| Targeted | medical condition treated | Epilepsy |
| Stratification | has effect | Result Reporting |
| Circuit | has part | Targets |
| 11 | instance of | Age Group |
| Sei | subclass of | Atmospheric Pressure |
| Neurostimula | subclass of | Closed-Loop |
| Cc | subclass of | Correlations |
| Correlations | has part | Influence |
| 1918 | point in time | 1918 |
| Seizure Activ | has part | Stimulation |
| Winter | subclass of | Associ |
| 130,226 | instance of | Ity |
| Viral | subclass of | Illnesses |
| Fever | subclass of | Illness |
| The Future Is Bright | author | John F. Kennedy |
| 2009 World Health Conference | point in time | 2009 |
| Confounding Factors | subclass of | Unaccounted |
| Confounding Factors | has effect | Certainty |
| Confounding Factors | studied by | Data Analysis |
| Sensitive Proteins | use | Optogenetics |
| The Chosen Strati | is a list of | Strati |
| Spinal Cord | connects with | Brain |
| Fication | instance of | Method |
| Basic Research | has part | Goal |
| Mechanical | facet of | Seizures |
| Confirmation Of Seizure | subclass of | Seizure |
| Surrogate Data | subclass of | Surrogate |
| Adaptive Epilepsy | subclass of | Epilepsy |
| Discussions | has part | Discussions |
| Emergency Medical Record | different from | Direct Data |
| Emergency Medical Record | different from | Electro |
| Direct Data | different from | Emergency Medical Record |
| Seizure Count | facet of | Patients |
| Seizure Count | has part | Pressure |
| Recurrent Seizure | subclass of | Seizures |
| Novel Treatment Strate | opposite of | Conventional Asms |
| Seizure Confirmation | subclass of | Surrogate Data |
| Indirectness | subclass of | Correlations |
| Contribute To Treatment | subclass of | Treatment |
| Weakens | opposite of | Weakens |
| Controversy | facet of | Literature |
| Medication Regimens | facet of | Epilepsy Management |
| One-Size-Fits-All | use | Forecasting |
| Medication Schedule | subclass of | Therapeutic |
| Individualized Algorithm | subclass of | Algorithm |
| Reduced Response To The Medication | subclass of | Resistant To Treatment |
| Pre-Ictal Hr Increase | part of | Pre-Ictal Hr |
| Mete | subclass of | Hrv |
| Variation | facet of | Litera |
| Direct Clinical Applications | subclass of | Optogenetics |
| Development Of Future Therapies | subclass of | Therapies |
| Novel Therapies | subclass of | Field |
| Staying Updated | facet of | Research |
| False Posi | instance of | Posi |
| T | instance of | Tive Rate |
| T | contains administrative territorial entity | De Vries |
| T | contains administrative territorial entity | Munteanu |
| One Study Assessing Environmental | main subject | Environmental |
| Positive | instance of | Biomarkers |
| Existing Therapies | subclass of | Indications |
| Maximum Station | different from | Ambient Temperature |
| Study Design | facet of | Design |
| Confounding Variables | subclass of | Possible |
| Emerging Therapies For Epilepsy Management | facet of | Epilepsy |
| Process | has part | Step |
| The Initial Level Of Certainty | facet of | Study |
| Low Level Of Certainty | subclass of | Certainty |
| Studies Reviewed | subclass of | Studies Reviewed |
| Downgrading | subclass of | Upgrading |
| Acupuncture | subclass of | Acupuncture |
| Measurement Bias | has effect | Large Effect |
| Measurement Bias | facet of | Graphically-Confirmed Methods |
| Synergistic Benefits | facet of | Epilepsy Treatment |
| Significance | facet of | Sample Size |
| Low Certainty | subclass of | Small |
| Low Certainty | subclass of | Downgrade |
| Treatment Regimens | facet of | Treatment |
| Data Analysis | studies | Data |
| Artificial | use | Artificial |
| Intelligence | has part | Accuracy |
| Genetic Information | has effect | Seizure Risk |
| Electro | different from | Emergency Medical Record |
| Treatment Response | number of participants | 231,232 |
| Algorithm Studies | subclass of | Studies |
| Low Cer | subclass of | Sensitivities |
| Limitations Of The | author | Esparza Et Al |
| Frontiers In Neurology | number of chapters | 10 |
| Frontiers In Neurology | number of chapters | 11 |
| Sample Sizes | part of | Duration |
| Adjunctive Treatment | subclass of | Monotherapy |
| Model | facet of | Machine Learning |
| Indi | instance of | Sample Sizes |
| Research And Development | has part | Preclinical |
| Conclusions | facet of | Conclusions |
| Trained | subclass of | Algorithms |
| False Positives | subclass of | Accuracy |
| Studies Reviewed Here | is a list of | Studies Reviewed |
| Studies Reviewed Here | main subject | Low Certainty |
| Monitoring Unit | facet of | Epilepsy |
| The Importance Of Staying Updated With Emerging | facet of | Emerging |
| Daily Lives | facet of | Patients’ Daily Lives |
| Combination Approaches | subclass of | Therapies |
| Hospital | subclass of | Setting |
| Collaborative | has part | Collaborative |
| The End Of The Affair | author | John F. Kennedy |
| Hope For A Brighter Future | facet of | Quality Of Life |
| Mortality | subclass of | Morbidity |
| Mortality | part of | Life |
| J | spouse | Shampa Ghosh |
| J | part of | French |
| J | part of | Langfitt |
| J | contains administrative territorial entity | Alcala-Zermeno |
| J | part of | Haskell |
| J | part of | Sellin |
| J | contains administrative territorial entity | Herrera-Santos |
| J | part of | Gonçalves |
| J | part of | Krauss |
| J | part of | Burattini |
| J | contains administrative territorial entity | Pimentel |
| J | part of | Herzog |
| J | part of | Schneiders |
| J | sibling | Willie |
| J | subsidiary | Ferrero |
| J | part of | Noebels |
| The Future Of Physics | author | John F. Kennedy |
| Long-Term Health Outcomes | has part | Deaths |
| Curation | part of | Data Collection |
| Biomark | subclass of | Biomark |
| Evidence-Based Investigations | subclass of | Predictive Capabilities |
| First Step | part of | Crucial |
| Editing | part of | Figure |
| Editing | part of | Writing |
| Editing | subclass of | Review |
| Well-Designed Studies | use | Biomarkers |
| Gloneuro | instance of | Research Support Funding |
| Gloneuro | country | India |
| Predictive Algorithm | subclass of | Algorithms |
| Not Applicable | subclass of | Statement |
| Not Applicable | subclass of | Informed Consent Statement |
| Combinations | subclass of | Biomarker |
| Data Availability Statement | instance of | Data Availability Statement |
| Data Availability Statement | subclass of | Availability Statement |
| The Weather Channel | headquarters location | Washington, D.C. |
| Combinations Of Biomarkers | subclass of | Biomarker |
| Optimized | facet of | Reason |
| Practicability | subclass of | Practicability |
| 2007 World Championships In Athletics | point in time | 2007 |
| Strong Evidence | subclass of | Evidence |
| Indian Council Of | member of | International Brain Research Organization |
| Icmr | country | India |
| Evidence-Based | facet of | Algo |
| Rithms | use | Seizure Forecasting |
| Rakesh Bhaskar | spouse | Kannan Badri Narayanan |
| The Original Contributions | facet of | Study |
| Conflicts Of Interest | different from | Conflict Of Interest |
| Conflict Of Interest | different from | Conflicts Of Interest |
| Author Contributions | published in | Journal Of Medical Research |
| Formal Analysis | part of | Methodology |
| Formal Analysis | subclass of | Editing |
| Methodology | subclass of | Writing |
| Methodology | part of | Investigation |
| Epilepsy And Social Identity | main subject | Chronic Neurological Disorder |
| Original Draft | subclass of | Writing |
| Original Draft | subclass of subclass of | Writing Writing |
| Writing | has part | Editing |
| Writing | subclass of | Writing |
| Writing | part of | Gad |
| Lancet Neurol | instance of | Neurol |
| Data Curation | part of | Conceptualization |
| Data Curation | subclass of | Writing |
| Data Curation | part of | Ab |
| Conceptualization | subclass of | Writing |
| 2005 | point in time | 2005 |
| O. Devinsky | religious order | O |
| Vezzani | league | A |
| A | sports league level | A |
| A | author | Silverberg |
| O’Brien | religious order | T |
| Origi | subclass of | Writing |
| Scheffer | father | I |
| I | child | Scheffer |
| I | contains administrative territorial entity | Pervaiz |
| I | has part | Ohmori |
| I | notable work | Mutchnick |
| I | has part | Ngadimon |
| I | has part | Gooneratne |
| I | child | Fischer |
| I | contains administrative territorial entity | Karakis |
| I | child | Miller |
| I | author | Chopra |
| I | sibling | Mcgregor |
| Nal Draft | subclass of | Writing |
| De Curtis | religious order | M |
| Perucca | located in the administrative territorial entity | P |
| Perucca | instance of | E |
| P | has part | Mcgoldrick |
| P | has part | P |
| Grd | facet of | Data Curation |
| Devaraju | religious order | K |
| Vaibhav | religious order | K |
| Pharmacological And Therapeutic Approaches | main subject | Therapeutic |
| Biomedicines 2021 | point in time | 2021 |
| Data Cura | developer | Jr |
| Acevedo | league | C |
| C | has part | C |
| Arzimanoglou | member of | A |
| Bogacz | country | A |
| Forsgren | instance of | L |
| L | sibling | Hirsch |
| L | contains administrative territorial entity | Hamiwka |
| L | contains administrative territorial entity | Minutoli |
| L | part of | Marcuse |
| L | capital | Vall |
| L | contains administrative territorial entity | Slagmolen |
| L | contains administrative territorial entity | Filipiuc |
| L | contains administrative territorial entity | Vandenberghe |
| L | country | Mexico |
| French | has part | J |
| Official Report | main subject | Epilepsy |
| Epilepsia 2014 | point in time | 2014 |
| 2014 | point in time | 2014 |
| Supporting Information | subclass of | Grants |
| Christina Roth | employer | Ut Austin |
| Revision | subclass of | Submission |
| Cannabidiol Therapy For Difficult-To-Treat Seizures In Children And Adults | part of | Therapeutic And Clinical Foundations Of Cannabidiol Therapy For Difficult-To-Treat Seizures In Children And Adults |
| Conflict Of Interest | has effect | Conflict Of Interest |
| Conflict Of Interest | has effect | Potential Conflict |
| 23,359,114237 | point in time | 23 |
| Theodor G. Wirth | notable work | Theodor G. Wirth |
| Fattorusso | member of | A |
| Commercial | subclass of | Financial Relationships |
| Matricardi | instance of | S |
| Mencaroni | instance of | E |
| E | part of | Koontz |
| E | manufacturer | Toyota |
| E | has part | E |
| Generative Ai Statement | facet of | Ai |
| Generative Ai | subclass of | Ai |
| Dell’Isola | instance of | G |
| G | part of | Kleiner-Fisman |
| G | contains administrative territorial entity | Verlengia |
| The Lost Symbol | author | John Milton |
| Di Cara | member of sports team | G |
| Alt Text | subclass of | Alternative Text |
| Striano | instance of | P |
| Frontiers | instance of | Artificial |
| Verrotti | league | A |
| Pharmacoresistant Epilepsy | subclass of | Epilepsy |
| Existant And New Emerging Therapies | subclass of | Therapies |
| Hirsch | sibling | L |
| The Daily Show | original broadcaster | Abc |
| Seizure Clusters, Rescue Treatments, Seizure Action Plans | main subject | Seizure Action Plan |
| Affiliated | has part | Authors |
| Formulations | subclass of | Formulation |
| Publisher | has part | Editors |
| Publisher | field of this occupation | Publisher |
| Claim | facet of | Product |
| Epilepsy Behav | instance of | Behav |
| Manufacturer | product or material produced | Guaranteed |
| Nadeem | father | Nadeem |
| Pervaiz | located in the administrative territorial entity | I |
| Cheema | award received | F |
| Epileptic Seizures | subclass of | Seizures |
| Rajput | instance of | S |
| Anwar H | member of sports team | Qu |
| Khan | member of sports team | Qu |
| Nadeem N | member of sports team | Qu |
| Pervaiz I | member of sports team | Qu |
| Ali M | member of sports team | Qu |
| Cheema Ff | member of sports team | Qu |
| Cicuta Virosa Medicinal Preparations Against Pentylenetetrazole-Induced Seizures | author | Efficacy Of Cicuta Virosa Medicinal Preparations Against Pentylenetetrazole-Induced Seizures |
| Discoveries (Craiova) | located in the administrative territorial entity | Craiova |
| M. Rogawski | member of political party | M. Rogawski |
| World Health Organization (2024) | point in time | 2024 |
| Löscher | located in the administrative territorial entity | W |
| Mechanisms Of Action Of Antiseizure Drugs And The Ketogenic Diet | facet of | Ketogenic Diet |
| Cold Spring Harb | instance of | Harb |
| 2016,6,A022780 | point in time | 2016 |
| 2016 | point in time | 2016 |
| Kumar G | sibling | Sharma V |
| Sharma V | sibling | Kumar G |
| Pediatric Neurology Disorders | subclass of | Clinical Profile Of Pediatric Neurology Disorders |
| Northwestern | country | India |
| Jacoby | member of | A |
| Stalgis | league | C |
| (2022) 14:E30359 | followed by | (2022) 14:E30359 |
| Monnet | religious order | D |
| D | instance of | D |
| Cureus | instance of | Cure |
| Quality Of Life Of People With Epilepsy | part of | European Study |
| Epilepsia 1997 | point in time | 1997 |
| Garcia P | instance of | P |
| 38 | number of episodes | 353 |
| Wolters Kluwer | inception | 2023 |
| Svendsen | located in the administrative territorial entity | K |
| Larsson | member of sports team | P |
| 2006 World Health Conference | point in time | 2006 |
| 2006 | point in time | 2006 |
| Johannessen | located in the administrative territorial entity | S |
| Johannessen | heritage designation | Landmark |
| Rainer Lj | member of | Granbichler Ca |
| Landmark | subclass of | C |
| Status Epilepticus | subclass of | Epilepsy |
| Safety Aspects Of Antiepileptic Drugs | facet of | Antiepileptic Drugs |
| (2023) 3 | part of | (2023) 3 |
| Population-Based Study Of Adverse Effects Relative To Changes In Utilisation | main subject | Adverse Effects |
| 1153 | point in time | 1153 |
| Szabó Cá | has part | Sp Jr |
| Asconap É | instance of | J |
| Am J Forensic Med Pathol | affiliation | Forensic Med Pathol |
| Some Common Issues In The Use Of Antiepileptic Drugs | facet of | Antiepileptic Drugs |
| 2018 | point in time | 2018 |
| Semin Neurol | instance of | Neurol |
| 08004 | point in time | 08005 |
| 2002 | point in time | 2002 |
| Tudor Ki | has part | Bujan Kovač A |
| Side Effects Of Antiepileptics | instance of | Review |
| 2004 | point in time | 2004 |
| Acta Clin Croat | main subject | Clin Croat |
| Stevelink | member of political party | R |
| Mulugeta H | has part | Minwuyelet F |
| Koeleman | award received | B |
| B | sports league level | B |
| Sander | religious order | J |
| Associated Factors | has effect | Epilepsy |
| Jansen | position played on team / speciality | F |
| (2022)17 | point in time | (2022)17 |
| Refractory Juvenile Myoclonic Epilepsy | instance of | Meta-Analysis |
| Prevalence | facet of | Risk Factors |
| Didelot A | has part | Bates E |
| The Impact Of Epilepsy On Quality Of Life | instance of | European Survey |
| Neurobiologic | part of | Clinical Mechanisms |
| Epilepsia 2005 | publication date | 2005 |
| (2023) 142 | number of participants | 109 |
| Impact Of Treatments | facet of | Epilepsy |
| Zaccariello | religious order | M |
| Pharmacoeconomics | field of work | Economics |
| Hamiwka | located in the administrative territorial entity | L |
| Wirrell | instance of | E |
| Yu Z | sibling | Shao Q |
| Shao Q | sibling | Yu Z |
| Qualitative Research | subclass of | Studies |
| Front Psych | subclass of | Psych |
| Iramiot | located in the administrative territorial entity | S |
| (2022) 13 | publication date | 987892 |
| Nekaka | located in the administrative territorial entity | R |
| Dumanis Sb | member of | Cl |
| Ssenyonga | instance of | L |
| Front Neurol | instance of | Neurol |
| Epilepsy Clinic | subclass of | Tertiary Hospital |
| (2021) 12:717428 | has part | (2021) 12:717428 |
| Plos One | has part | E0274373 |
| E0274373 | part of | Plos One |
| Perferi G | has part | Colicchio G |
| Camfield | position held | C |
| Ar Models | uses | Support Vector Machines |
| Support Vector Machines | use | Ar Models |
| Facts And Opinions | has part | Opinions |
| Opinions | subclass of | Statements |
| Daoud | sibling | Williams P |
| Williams P | sibling | Daoud |
| Trinka | ranking | E |
| Efficient Epileptic Seizure Prediction | instance of | Iot |
| Deep Learning | use | System Using Deep Learning |
| Cendes | ranking | F |
| 6Th World Forum On Internet Of Things | organizer | Ieee |
| Ieee | subsidiary | Med Biol Soc |
| Langfitt | has part | J |
| New Orleans | located in the administrative territorial entity | La |
| La | capital | New Orleans |
| Delanty | located in the administrative territorial entity | N |
| N | contains administrative territorial entity | Delanty |
| N | contains administrative territorial entity | Velez-Ruiz |
| N | contains administrative territorial entity | Zamponi |
| N | contains administrative territorial entity | Shapira |
| N | has part | Sisterson |
| N | contains administrative territorial entity | Teixeira |
| N | contains administrative territorial entity | Colleran |
| N | contains administrative territorial entity | Rezaei |
| N | contains administrative territorial entity | Aladamat |
| N | contains administrative territorial entity | Sanlier |
| N | capital | Boulis |
| N | contains administrative territorial entity | Truong |
| The Tender Hook | author | John F. Kennedy |
| 9221169 | instance of | Document |
| Benbadis | country | S |
| Roy | member of political party | Pp |
| The Consequences Of Refractory | main subject | Refractory |
| Epileptic Seizure Prediction | subclass of | Prediction |
| Epilepsy And Its Treatment | subclass of | Its Treatment |
| Pre-Ictal Phase | part of | Eeg |
| Signal Process Control | instance of | Control |
| Mcdonald | occupation | Jt |
| Sisodiya | located in the administrative territorial entity | S |
| Forewarning Of Epileptic Events | facet of | Epileptic Events |
| Walker | religious order | M |
| Adult Epilepsy | subclass of | Epilepsy |
| 2013 Biomedical Sciences And Engineering Conference | point in time | 2013 |
| 2013 | point in time | 2013 |
| Institute Of Electrical And Electronics Engineers | located in the administrative territorial entity | Ridge, Tn |
| Potschka | country | H |
| Mckeown | occupation | Mj |
| Semi-Dilated Convolutional Neural Network | subclass of | Convolutional Neural Networks |
| Drug Resistance In Epilepsy | facet of | Epilepsy |
| Neural Net | instance of | Netw |
| New Innovative Treatment Options | main subject | Innovative Treatment |
| (2021) 139 | followed by | (2021)212–22 |
| Muñoz-Almaraz | member of | Fj |
| Epilepsy Forecasting | subclass of | Forecasting |
| 12:E0178808 | part of | E0178808 |
| Truong Nd | member of | Nd |
| Tomson | instance of | T |
| Convolutional Neural Network | use | Seizure Prediction |
| Electroencephalogram | subclass of | Electroencephalogram |
| Host Factors Affecting Antiepileptic Drug Delivery-Pharmacokinetic | facet of | Antiepileptic Drug Delivery-Pharmacokinetic |
| Dahm P | instance of | Da |
| Urzìbrancati | religious order | V |
| Evaluating The Certainty Of Evidence | facet of | Evidence-Based |
| Pinto Vraca | country | T |
| Eur Urol Focus | part of | Urol Focus |
| Minutoli | located in the administrative territorial entity | L |
| Recommendations | subclass of | Recommendation |
| Pallio | religious order | G |
| Clin Epidemiol Glob Health | field of work | Glob Health |
| Polymorphisms Affecting The Response To Novel Antiepileptic Drugs | facet of | Antiepileptic Drugs |
| (2024) 25 | publication date | 2021 |
| Sun Wz | instance of | Mh |
| Data Mining | studies | Time Series |
| Patsalos | located in the administrative territorial entity | P |
| Comput Electr | instance of | Electr |
| Clinically Important Drug Interactions In Epilepsy | facet of | Epilepsy |
| Compeleceng | sport | Football |
| Antiepileptic | subclass of | Drugs |
| El Atrache R | has part | Vieluf S |
| El Atrache R | has part | Jackson M |
| Vieluf S | part of | Reinsberger C |
| 2003 | point in time | 2003 |
| Seizure-Related | has effect | Seizure |
| (2022) 12 | point in time | 15070 |
| S41598-022-18271-Z | publication date | 22 February 2018 |
| Neurobiology Of Antiepileptic Drugs | subclass of | Neurobiology |
| Pearl Pl | has part | Stamoulis C |
| Kobayashi | instance of | K |
| Ohmori | part of | I |
| Med Biol Soc | parent organization | Ieee |
| Akiyama | instance of | T |
| 1109 | point in time | 1109 |
| Neurons | connects with | Neuron |
| Van Huffel S | part of | Lagae L |
| Lagae L | has part | Van Huffel S |
| Epi | subclass of | Ecg |
| Medication Adherence | facet of | Medication |
| Detection Systems | use | Detection |
| Epileptic Disord | has part | Epileptic Disord |
| Antiepilepsy Drug Therapy | has part | Adherence To Antiepilepsy Drug Therapy |
| Tsiknakis | member of political party | Vorgia P |
| Difficulties In Treatment And Management Of Epilepsy | facet of | Epilepsy |
| Comput Methods Prog Biomed | subclass of | Biomed |
| Pharmaceuticals | subclass of | Pharmaceutical |
| Henriques J | award received | Mg |
| Schmidt | member of political party | D |
| 1038 | point in time | 1038 |
| Epilepsia 2006 | publication date | 2006 |
| Billeci L | sibling | Marino D |
| Marino D | sibling | Billeci L |
| Lhatoo | located in the administrative territorial entity | S |
| Cns Adverse Events Associated With Antiepileptic Drugs | facet of | Antiepileptic Drugs |
| Cns Drugs | publication date | 2008 |
| Quint Sr | award received | Bv |
| Monitoring Heart Period | main subject | Heart |
| Modern Management Of Epilepsy | main subject | Epilepsy |
| Diversity And Trends | instance of | Trends |
| Francis-Auton | instance of | E |
| Nikpour | instance of | A |
| Herkes | religious order | G |
| Bleasel | league | A |
| Rapport | instance of | F |
| Suzuki Y | has part | Watanabe Y |
| Watanabe Y | part of | Suzuki Y |
| Interlinking Multiple Social And Relational Determinants | facet of | Patients |
| Sensors (Basel) | located in the administrative territorial entity | Basel |
| Johnson | position held | G |
| Johnson | has part | E |
| Johnson | member of | A |
| Johnson | religious order | N |
| Johnson | member of sports team | B |
| Englot | instance of | D |
| Integrating Network Neuroscience Into Epilepsy Care | main subject | Epilepsy |
| Reinsberger C | has part | Vieluf S |
| Epilepsy Curr | field of work | Epilepsy |
| Sullivan | father | J |
| Auguste | religious order | K |
| Jackson M | part of | El Atrache R |
| Pediatric Drug-Resistant Epilepsy | subclass of | Treatment Of Pediatric Drug-Resistant Epilepsy |
| Viana | occupation | Pf |
| Epilepsy Monitoring | subclass of | Wearables |
| Meador | located in the administrative territorial entity | K |
| Subramanian | member of | En |
| Precision Medicine In Women With Epilepsy | published in | Systematic Review |
| Temporal Structure | facet of | Point Process |
| Future Direction | part of | Future Direction |
| Proc Natl Acad Sci Usa | country | Usa |
| 107928 | point in time | 1079 |
| Shamay | located in the administrative territorial entity | Y |
| Wassenaar M | member of | Sonsma A |
| Kiguchi | instance of | H |
| Seizure Precipitants In Dravet Syndrome | facet of | Dravet Syndrome |
| Scaltriti | instance of | M |
| Epilepsies | subclass of | Epilepsies |
| Heller | member of political party | D |
| Precision | facet of | Precision |
| 2015 | point in time | 2015 |
| Steinbusch Lc | member of | Fe |
| Stress Sensitivity | subclass of | Sensitivity |
| Childhood Epilepsy | subclass of | Epilepsy |
| Fujinami | member of | Rs |
| Viral Trigger | subclass of | Triggers |
| Inflammatory Mechanisms | facet of | Epilepsy |
| Madireddy | located in the administrative territorial entity | S |
| Mol Neurobiol | instance of | Neurobiol |
| 1035 | point in time | 1035 |
| Ampofo K | member of | Korgenski Ek |
| Neuronal Damage In Epilepsy | has cause | Regulating Oxidative Stress |
| Regulating Oxidative Stress | has effect | Neuronal Damage In Epilepsy |
| H1N1 Influenza | has effect | Pandemic |
| Neuroinflammation | has cause | Mitochondrial Dysfunction |
| Scoping Review | has part | Scoping Review |
| Swartz | league | B |
| Amsterdam | country | The Netherlands |
| The Netherlands | capital | Amsterdam |
| 978-0-323-91702-5 | publication date | 978 |
| Meinert | religious order | J |
| Stabingas | located in the administrative territorial entity | K |
| Whiting | instance of | A |
| Systematic Review And Meta-Analysis Of Responsive Neurostimu | followed by | Meta-Analysis Of Responsive Neurostimu |
| Lation In Epilepsy | facet of | Epilepsy |
| World Neurosurg | field of work | Neurosurg |
| Chapman | league | B |
| Mutchnick | author | I |
| Neimat | located in the administrative territorial entity | J |
| Neurostimu | subclass of | Thalamic Responsive |
| Motamedi | league | G |
| Diagnosis And Surgical Treatment Of Drug-Resistant Epilepsy | facet of | Drug-Resistant Epilepsy |
| Kouzani | league | A |
| Neurostimulation Devices For The Treatment Of Neurologic Disorders | medical condition treated | Neurologic Disorders |
| Neuromodulation In Drug-Resistant Epilepsy | subclass of | Drug-Resistant Epilepsy |
| Acta Neurol | main subject | Neurol |
| Bujarski | located in the administrative territorial entity | K |
| Burdette | religious order | D |
| Geller | has part | E |
| Velez-Ruiz | located in the administrative territorial entity | N |
| Neuromodulation In Drug Resistant Epilepsy | medical condition treated | Drug Resistant Epilepsy |
| 1070 | followed by | 1080 |
| King-Stephens | member of | D |
| Massey | member of | A |
| Barkley | position played on team / speciality | G |
| Salanova | instance of | V |
| Respon | subject has role | Medically Intractable Partial Onset Epilepsy Treated With Respon- |
| Morrell | religious order | M |
| Mizrahi | instance of | E |
| Goldman | instance of | A |
| Srinivasan | religious order | S |
| Responsive Brain Stimulation | medical condition treated | Seizures |
| Csernyus | religious order | B |
| Z Átonyi | member of | A |
| L Ázár | religious order | C |
| Pongr Ácz | league | A |
| Fekete | country | Z |
| Z | contains administrative territorial entity | Aghajan |
| Multimodal | subclass of | Implantable Sensor Array |
| Hypothermia | has effect | Epileptic Seizure |
| Azagury | religious order | D |
| Barbosa | religious order | D |
| Williams | instance of | N |
| Williams | religious order | S |
| Williams | member of political party | R |
| Brain-Responsive Neurostimulation For Loss Of Control Eating | part of | Early Feasibility Study |
| Neurosurgery 2020 | point in time | 2020 |
| Alcala-Zermeno | located in the administrative territorial entity | J |
| Starnes | member of | K |
| Worrell | religious order | G |
| Lundstrom | league | B |
| Responsive Neurostimulation With Low-Frequency | subclass of | Neurostimulation |
| The Rns System | main subject | Epilepsy |
| Ngadimon | part of | I |
| Aledo-Serrano | instance of | A |
| Arulsamy | instance of | A |
| Cheong | religious order | W |
| Shaikh | religious order | M |
| Interplay Between | subclass of | Interplay |
| Post-Traumatic Epilepsy | has effect | Associated Cognitive Decline |
| Kerezoudis | religious order | P |
| Gyftopoulos | award received | A |
| Alexander | member of | A |
| Keith Starnes | member of political party | D |
| Nickels | located in the administrative territorial entity | K |
| Van Gompel | religious order | J |
| Miller | religious order | K |
| Miller | father | I |
| Institutional Review | instance of | Meta-Analysis |
| Ganaha | located in the administrative territorial entity | S |
| Haskell | has part | J |
| Fields | religious order | M |
| La Vega-Talbott | religious order | M |
| Marcuse | has part | L |
| Ghatan | located in the administrative territorial entity | S |
| Neurostimulation In Pediatric Patients With Medically Refractory Epilepsy | subclass of | Neurostimulation In Pediatric Patients With Pediatric Patients With Medically Refractory Epilepsy |
| Gooneratne | part of | I |
| Franzini | instance of | A |
| Cheeran | league | B |
| Neurostimulation Technologies | studies | Neurostimulation |
| Refractory Focal-Onset Epilepsy | subclass of | Epilepsy |
| Richardson | member of political party | R |
| Carmichael | member of political party | D |
| Baldeweg | country | T |
| Denison | located in the administrative territorial entity | T |
| Tisdall | award received | M |
| Towards Network | instance of | Network |
| Guided Neuromodulation For Epilepsy | medical condition treated | Epilepsy |
| Brain 2022 | point in time | 2022 |
| Therapeutic Devices For Epilepsy | medical condition treated | Epilepsy |
| Schupper | has part | A |
| Centromedian | subclass of | Thalamic |
| Lennox-Gastaut Epilepsy | has effect | Autism |
| Samala | member of political party | R |
| Chandra | religious order | P |
| Tripathi | instance of | M |
| Neuroengineering | subclass of | Engineering |
| Therapeutic Mechanisms Of Vagus Nerve Stimulation | studies | Vagus Nerve Stimulation |
| Neurology 2002 | point in time | 2002 |
| Sinniger | instance of | V |
| Pellissier | instance of | S |
| Albusoda | located in the administrative territorial entity | A |
| Farmer | member of | A |
| Anatomical Basis For Transcutaneous Auricular Vagus Nerve Stimulation | facet of | Transcutaneous Auricular Vagus Nerve Stimulation |
| Transcutaneous Auricular Vagus Nerve Stimulation | subclass of | Stimulation |
| Raycraft | instance of | L |
| Lateral Hypothalamic Orexin | subject has role | Dynamic Regulation Of Appetitive Behavior |
| Melanin Concentrating Hormone Expressing Cells | subclass of | Concentrating Hormone Expressing Cells |
| Ulrich-Lai | located in the administrative territorial entity | Y |
| Herman | religious order | J |
| Autonomic | part of | Neurobiology |
| Ta-Vns | medical condition treated | Drug-Resistant Epilepsy |
| Neurotherapeutics | publication date | 2023 |
| Mccormick | member of | D |
| Zamponi | located in the administrative territorial entity | N |
| Varadkar | member of political party | S |
| Feucht | religious order | M |
| Parain | religious order | D |
| Griens | member of political party | R |
| Vall Ée | located in the administrative territorial entity | L |
| Rittey | religious order | C |
| Nerve Stimulation For Drug-Resistant Epilepsy | instance of | Long-Term Study |
| 1576 | point in time | 1576 |
| Beekwilder | religious order | J |
| Clinical Applications Of Vagus Nerve Stimulation | studies | Vagus Nerve Stimulation |
| Neurophysiol | has part | Neurophysiology |
| Neurophysiology | part of | Neurophysiol |
| Neurophysiology | has part | Optogenetics |
| Cns Neurosci | instance of | Neurosci |
| 1222 | point in time | 1222 |
| Dibué-Adjei | religious order | M |
| Fischer | father | I |
| Steiger | instance of | H |
| Adjunctive Vagus Nerve Stimulation | medical condition treated | Dravet |
| Syndrome | instance of | Meta-Analysis |
| Seizure 2017 | point in time | 2017 |
| Kalhorn | instance of | S |
| Marcus | position held | J |
| Sellin | has part | J |
| Silverberg | notable work | A |
| Rivera | instance of | E |
| Carlson | member of | C |
| Nerve Stimulation In 436 Consecutive Patients With Treatment-Resistant Epilepsy | main subject | Long-Term Outcomes And Predictors Of |
| Boffini | country | M |
| Gordon | member of | C |
| Tzadok | country | M |
| El Tahry | member of political party | R |
| Vns Parameters For Clinical Response In Epilepsy | facet of | Epilepsy |
| Brain Stimul | instance of | Stimul |
| Desmarteau | religious order | J |
| Koontz | has part | E |
| Melamed | instance of | S |
| Responsive Vagus Nerve Stimulation For Drug Resistant | medical condition treated | Drug Resistant |
| Harush | instance of | A |
| Nissenkorn | league | A |
| Zauberman | instance of | Y |
| Feldman | member of | Z |
| Ben-Zeev | league | B |
| Vagal | subclass of | Clinical Outcomes Of Closed-Loop |
| Nerve Stimulation In Patients With Refractory Epilepsy | facet of | Refractory Epilepsy |
| Seizure 2019 | point in time | 2019 |
| Gadeyne | located in the administrative territorial entity | S |
| Carrette | instance of | E |
| Devices 2018 | publication date | 2018 |
| Canal-Alonso | located in the administrative territorial entity | Á |
| Casado-Vara | instance of | R |
| Castellano | religious order | O |
| Herrera-Santos | located in the administrative territorial entity | J |
| Gonçalves | has part | J |
| M Àrquez-S Ànchez | has part | S Ànchez |
| S Ànchez | part of | M Àrquez-S Ànchez |
| Corchado | instance of | J |
| An Affordable Implantable Vagus Nerve Stimulator System For Use In Animal Research | use | Animal Research |
| Adamolekun | league | B |
| Aydemir | located in the administrative territorial entity | S |
| Watson | award received | G |
| Watson | member of sports team | C |
| Evolution Of The Vagus Nerve Stimulation | facet of | Vagus Nerve Stimulation |
| Technology For Drug-Resistant Epilepsy | medical condition treated | Epilepsy |
| Vagus Nerve Stimulation For Pediatric | medical condition treated | Pediatric |
| Double-Blind | subclass of | Randomized Control Trial |
| Serdaroglu | member of | A |
| Durda | has part | E |
| Aksakal | instance of | F |
| Ozcelik | league | A |
| Baykaner | located in the administrative territorial entity | K |
| Efficacy Of Vagal | located in the administrative territorial entity | Vagal |
| Nerve Stimulation In Children With Pharmacoresistant Epilepsy | country of origin | Turkish |
| Asadi-Pooya | instance of | A |
| Lennox-Gastaut Syndrome | instance of | Comprehensive Review |
| Lennox-Gastaut Syndrome | author | Expert Opinion On The Management Of Lennox-Gastaut Syndrome |
| Lennox-Gastaut Syndrome | subclass of | Dravet |
| Lennox-Gastaut Syndrome | has part | Cannabidiol |
| Lennox-Gastaut Syndrome | subclass of | Epileptic Conditions |
| Treatment Algorithms And Practical Considerations | has part | Practical Considerations |
| Practical Considerations | part of | Treatment Algorithms And Practical Considerations |
| Workewych | instance of | A |
| Mithani | instance of | K |
| Ibrahim | award received | G |
| Biomarkers Of Seizure Response To Vagus Nerve Stimulation | subclass of | Biomarkers Of Seizure Response To Vagus Nerve Stimulation |
| Diener | instance of | H |
| Silver | instance of | N |
| Reuter | country | U |
| Andersson | league | A |
| Andersson | religious order | M |
| Liebler | has part | E |
| Straube | instance of | A |
| Preva Study Group | instance of | Study Group |
| Preva | medical condition treated | Cluster Headache |
| Controlled Study | instance of | Study |
| Cephalalgia 2016 | point in time | 2016 |
| Therapeutic Effect Of Implanted | facet of | Implanted |
| Non-Invasive Vagus Nerve Stimulation | medical condition treated | Heroin-Induced Anxiety |
| Abouelleil | religious order | M |
| Deshpande | religious order | N |
| Emerging Trends In Neuromodulation For Treatment Of Drug-Resistant Epilepsy | main subject | Neuromodulation |
| Sandner | award received | K |
| Glaser | religious order | M |
| Ciolac | religious order | D |
| Ziebart | instance of | A |
| Karakoyun | instance of | A |
| Chiosa | located in the administrative territorial entity | V |
| Saryyeva | award received | A |
| Krauss | has part | J |
| Krauss | religious order | G |
| The Last Man | author | John Osborne |
| Cukiert | instance of | C |
| Burattini | has part | J |
| Guimaraes | located in the administrative territorial entity | R |
| Combined Neuromodulation | has part has part | Vagus Nerve Stimulation Deep |
| Deep | part of | Combined Neuromodulation |
| Neuromodulation 2022 | point in time | 2022 |
| Brain-Clinical Signatures For Vagus Nerve Stimulation Response | facet of | Vagus Nerve Stimulation Response |
| Lamarre | located in the administrative territorial entity | E |
| Lorenz | member of political party | R |
| Bryson | instance of | P |
| Laryngology Outcomes Following Implantable Vagus | facet of | Implantable Vagus |
| Nerve Stimulation | subclass of | Stimulation |
| Jama Otolaryngol | language of work or name | Otolaryngol |
| Head Neck Surg | subclass of | Surg |
| Paul Amar | member of | A |
| Apuzzo | instance of | M |
| Elsevier | headquarters location | Amsterdam |
| 0-12-374248-3 | publication date | 978 |
| Gonz Ález | religious order | H |
| Yengo-Kahn | award received | A |
| Vagus Nerve Stimulation For The Treatment Of Epilepsy | medical condition treated | Epilepsy |
| Parhizgar | religious order | F |
| Nugent | religious order | K |
| Obstructive Sleep Apnea | subclass of | Respiratory Complications Associated With Vagus Nerve |
| Stimulator | subclass of | Stimulators |
| Abdullahi | member of | A |
| Badaru | country | U |
| Elibol | instance of | N |
| Abuelsamen | located in the administrative territorial entity | A |
| Alawneh | instance of | A |
| Zakari | country | U |
| Truijen | country | S |
| Nerve Stimulation For The Treatment Of Epilepsy | main subject | Epilepsy |
| Edwards | position held | J |
| Marzec | located in the administrative territorial entity | M |
| Sagher | religious order | O |
| Fromes | religious order | G |
| Respiration During Sleep | part of | Sleep |
| Pilot Study | instance of | Pilot Study |
| Gaitanis | religious order | J |
| Neuromodulation For The Treatment Of Epilepsy | medical condition treated | Epilepsy |
| Deep Brain Stimulation For Drug-Resistant Epilepsy | medical condition treated | Drug-Resistant Epilepsy |
| Epilepsia 2018 | point in time | 2018 |
| Taghva | instance of | A |
| Surgery Of The Mind, Mood, And Conscious State | main subject | Evolution |
| Chandrabhatla | award received | A |
| Pomeraniec | country | I |
| T. Horgan | position held | T |
| Ksendzovsky | instance of | A |
| Landscape And Future Directions Of Machine | main subject | Machine |
| Learning Applications In Closed-Loop Brain Stimulation | studies | Closed-Loop Brain Stimulation |
| Closed-Loop Brain Stimulation | studied by | Learning Applications In Closed-Loop Brain Stimulation |
| Closed-Loop Brain Stimulation | medical condition treated | Drug-Resistant |
| Giordano | religious order | J |
| Boyden | instance of | E |
| Gradinaru | located in the administrative territorial entity | V |
| Gunduz | instance of | A |
| Mcintyre | position held | C |
| Coolen | instance of | S |
| Fernandes | league | F |
| Schuurman | member of political party | R |
| Schuurman | member of | P |
| Groenewegen | located in the administrative territorial entity | H |
| Van Den Munckhof | located in the administrative territorial entity | P |
| Intralaminar | has part | Intralaminar |
| Brain Commun | has part | Brain Communic |
| 2023,5,Fcad003 | point in time | 2323 |
| Grogan | member of | D |
| Laxpati | located in the administrative territorial entity | N |
| Skelton | instance of | H |
| Isbaine | league | F |
| Gutekunst | instance of | C |
| Medial Septum | medical condition treated | Temporal Lobe Epilepsy |
| Epilepsia 2022 | point in time | 2022 |
| Van Drongelen | religious order | W |
| Electrical Control Of Epilepsy | facet of | Epilepsy |
| Lipsman | instance of | N |
| Bergman | has part | H |
| Chabardes | located in the administrative territorial entity | S |
| Matthews | award received | K |
| Schlaepfer | instance of | T |
| M. Schulder | religious order | M |
| Kasoff | religious order | W |
| Deep Brain Stimulation For The Treatment Of Epilepsy | medical condition treated | Epilepsy |
| Neurotherapeutics 2014 | point in time | 2014 |
| Van Den Brink | religious order | W |
| Feenstra | instance of | M |
| Schippers | member of political party | R |
| Mazaheri | instance of | A |
| De Vries | located in the administrative territorial entity | T |
| Deep Brain Stimulation In Addiction | main subject | Brain Stimulation |
| Lozano | instance of | A |
| Focus 2010 | point in time | 2010 |
| Pimentel | located in the administrative territorial entity | J |
| Coenen | instance of | V |
| Gil-Nagel | instance of | A |
| Gonçalves Ferreira | member of sports team | A |
| Lehtimäki | located in the administrative territorial entity | K |
| Ryvlin | instance of | P |
| Taylor | member of political party | R |
| Ackermans | located in the administrative territorial entity | L |
| Multicenter Patient Registry | instance of | Registry |
| Neurology 2023,100, E1852–E1865 | point in time | 2023 |
| Toyota | product or material produced | E |
| Anderson | religious order | M |
| Donner | instance of | E |
| A Systematic Review | instance of | Systematic Review |
| Nazzaro | religious order | J |
| Sperling | religious order | M |
| Sharan | instance of | A |
| Sandok | located in the administrative territorial entity | E |
| Drug-Resistant Partial Epilepsy | subclass of | Epilepsy |
| Neurology 2015 | point in time | 2015 |
| Shivacharan | member of political party | R |
| Cunningham | instance of | T |
| Keller | position held | C |
| Nucleus Accumbens | subject has role | Brain Stimulation |
| 1791–1796 | point in time | 1791 |
| Sutton | league | B |
| Winston | religious order | H |
| Abosch | instance of | A |
| Thompson | position held | J |
| Deep Brain Stimulation For Obsessive-Compulsive | medical condition treated | Obsessive-Compulsive |
| The End Of Days | author | John F. Kennedy |
| Gabriels | instance of | L |
| Malone | member of | D |
| Friehs | instance of | G |
| Shapira | located in the administrative territorial entity | N |
| Cosyns | instance of | P |
| Ventral Striatum | part of | Ventral Internal Capsule |
| Worldwide Experience | conflict | World War Ii |
| Psychiatry 2010 | point in time | 2010 |
| Boutet | instance of | A |
| Davidson | league | B |
| Technology Of Deep Brain Stimulation | main subject | Deep Brain Stimulation |
| Herzog | has part | J |
| Kleiner-Fisman | has part | G |
| Rodriguez-Oroz | instance of | M |
| Tröster | instance of | A |
| S219 | followed by | S237 |
| Surgical And Hardware Complications Of Deep Brain Stimulation | main subject | Deep Brain Stimulation |
| Over 20 Years | is a list of | Cases |
| Belluscio | instance of | M |
| Buzs Áki | award received | G |
| Transcranial Electrical Stimulation | medical condition treated | Epilepsy |
| Ber Ényi | instance of | A |
| Closed Loop Electrical Stimulation | medical condition treated | Absence Epilepsy |
| Closed-Loop Direct Control Of Seizure Focus | part of | Rodent Model |
| Localized Electric Fields Applied Sequentially | subclass of | Epilepsy |
| Closed-Loop Neuromodulation | part of | Physiological And Translational Research |
| Closed-Loop Neuromodulation | medical condition treated | Treatment-Resistant Post-Traumatic Stress Disorder |
| Romero-Ugalde | instance of | H |
| Le Rolle | located in the administrative territorial entity | V |
| Bonnet | religious order | J |
| Carrault | award received | G |
| Hernandez | league | A |
| Stimulation Based On State Transition Models | facet of | State Transition Models |
| 1630–1638 | point in time | 1630 |
| Kastner | instance of | S |
| Promises And Limitations Of Human Intracranial Electroencephalography | facet of | Human Intracranial Electroencephalography |
| Bruzzone | instance of | M |
| Lodovichi | language used | C |
| Dal Maschio | religious order | M |
| Optogenetic Methods To Investigate Brain Alterations In Preclinical | main subject | Optogenetic |
| Cells 2022,11,1848 | point in time | 1848 |
| Takeuchi | instance of | Y |
| Harangoz Ó | religious order | M |
| Pedraza | located in the administrative territorial entity | L |
| Koz Ák | religious order | G |
| Brain 2021 | point in time | 2021 |
| Parastarfeizabadi | country | M |
| Deep Brain Stimulation Devices | part of | Deep Brain |
| Integrated Circuit | part of | Circuit |
| Interface Systems | product or material produced | Interface Systems |
| Schneiders | has part | J |
| Stangl | instance of | M |
| Aghajan | located in the administrative territorial entity | Z |
| Vallejo | instance of | M |
| Hiller | instance of | S |
| Topalovic | member of sports team | U |
| Villaroman | religious order | D |
| Sisterson | part of | N |
| Kokkinos | country | V |
| Constantino | league | A |
| Neurotherapeutics 2019 | publication date | 2019 |
| Abramova | instance of | M |
| Vega-Talbott | instance of | M |
| Responsive Neurostimulation Of The Thalamus | medical condition treated | Refractory Epilepsy |
| Bullinger | religious order | K |
| Dickey | league | A |
| Karakis | located in the administrative territorial entity | I |
| Alwaki | instance of | A |
| Cabaniss | league | B |
| Winkel | member of political party | D |
| Rodriguez-Ruiz | league | A |
| Willie | sibling | J |
| Santacruz | located in the administrative territorial entity | S |
| Alexandrov | award received | G |
| Burghardt | instance of | F |
| Rabaey | religious order | J |
| Carmena | religious order | J |
| Muller | member of political party | R |
| Closed Loop Deep Brain Stimulation | subclass of | Deep Brain Stimulation |
| Vassileva | award received | A |
| Van Blooijs | religious order | D |
| Leijten | instance of | F |
| Huiskamp | located in the administrative territorial entity | G |
| Neocortical Electrical Stimulation For Epilepsy | medical condition treated | Epilepsy |
| Epilepsy Res | facet of | Epilepsy |
| Perez Velazquez | member of sports team | J |
| Closed-Loop Versus Open-Loop Deep Brain | subclass of | Seizure Suppression Efficacy |
| Stimulation In A Rodent Model Of Epilepsy | main subject | Rodent Model Of Epilepsy |
| Yousefi | instance of | A |
| Crocker | league | B |
| Zelmann | member of political party | R |
| Ellard | religious order | K |
| Weisholtz | religious order | D |
| Cosgrove | located in the administrative territorial entity | G |
| Deckersbach | located in the administrative territorial entity | T |
| Closed-Loop Enhancement And Neural Decoding | facet of | Cognitive Control |
| Khodagholy | religious order | D |
| Ferrero | parent organization | J |
| Gelinas | religious order | J |
| Ramgopal | religious order | S |
| Thome-Souza | located in the administrative territorial entity | Souza |
| Souza | contains administrative territorial entity | Thome-Souza |
| Jackson | instance of | M |
| Kadish | instance of | N |
| S Ánchez Fern Ández | father | I |
| Reinsberger | position held | C |
| Schachter | instance of | S |
| Loddenkemper | instance of | T |
| Neurostimulation Systems For The Control Of Refractory Epilepsy | medical condition treated | Epilepsy |
| Fonseca | league | B |
| Teixeira | located in the administrative territorial entity | N |
| Correia-Da-Silva | instance of | G |
| Cannabinoids | subject has role | Enhancers |
| De Luca | religious order | M |
| Miliano | position held | C |
| Hero | opposite of | Villain |
| Adolescent Exposure | has part | Insights Into Adolescent Exposure |
| Schouten | instance of | M |
| Slagmolen | located in the administrative territorial entity | L |
| Molecular Networks Underlying Cannabinoid Signaling In Skeletal | facet of | Cannabinoid Signaling In Skeletal |
| Muscle Plasticity | subclass of | Plasticity |
| Crescente | religious order | G |
| Minervini | religious order | G |
| Spagnuolo | position played on team / speciality | C |
| Moccia | located in the administrative territorial entity | S |
| Bioactive Compound-Based Formulations | subclass of | Cannabis |
| Orofacial Pain | subclass of | Management Of Orofacial Pain |
| Whalley | league | B |
| Proposed Mechanisms Of Action Of Cbd In Epilepsy | facet of | Epilepsy |
| Cannabidiol Inhibits Febrile Seizure | medical condition treated | Febrile Seizure |
| Febrile Seizure | drug used for treatment | Cannabidiol Inhibits Febrile Seizure |
| Glua1 | has part | Glua2 |
| Filipiuc | located in the administrative territorial entity | L |
| Ababei | instance of | D |
| Alexa-Stratulat | operating system | T |
| Pricope | instance of | C |
| Stefanescu | member of political party | R |
| Stanciu | award received | G |
| Major | has part | Phyto |
| Tics2021 | point in time | 1823 |
| Bialer | religious order | M |
| Cannabidiol In The Treatment Of Epilepsy | medical condition treated | Epilepsy |
| Checketts | member of political party | D |
| Flamini | member of | R |
| Nichol | religious order | K |
| Expanded Access Program | facet of | Syndrome |
| Coates | religious order | S |
| Lazarus | religious order | P |
| Cannabinoids And Drug Metabolizing Enzymes | facet of | Drug-Drug |
| Interactions And Implications For Drug Safety And Efficacy | facet of | Efficacy |
| 1443–1460 | point in time | 1443 |
| Alsherbiny | religious order | M |
| Medicinal Cannabis-Potential Drug Interactions | facet of | Potential Drug Interactions |
| Medicines 2018 | point in time | 2018 |
| Gruber | has part | S |
| Contemplating Cannabis | main subject | Cannabis |
| Potential For Drug-Drug Interactions | facet of | Drug-Drug Interactions |
| Kander | member of political party | R |
| The Sustainability Of Industrial Hemp | instance of | Literature Review |
| Sustainability | facet of | Sustainability |
| Sustainability 2023 | point in time | 2023 |
| Lordan | religious order | R |
| Horba | instance of | Nczuk |
| Atanasov | instance of | A |
| Chopra | notable work | I |
| J Ó´ Zwik | member of | A |
| Pirgozliev | instance of | V |
| The Current Use And Evolving Landscape Of Nutraceuticals | main subject | Landscape Of Nutraceuticals |
| Villanueva | instance of | M |
| Joshaghani | located in the administrative territorial entity | N |
| Saddik | country | S |
| Dawood | religious order | S |
| Efficacy, Safety, And Regulation Of Cannabidiol On Chronic Pain | instance of | Systematic Review |
| Mccartney | member of | D |
| Suraev | instance of | A |
| Mcgregor | sibling | I |
| Medical Cannabis Administration And Dosing | facet of | Medical Cannabis |
| Lattanzi | instance of | S |
| Zaccara | instance of | G |
| La Neve | instance of | A |
| Pharmaceutically Purified Oral | subclass of | Pharmaceutically |
| Rocchi | member of | C |
| Salvemini | located in the administrative territorial entity | S |
| Silvestrini | religious order | M |
| Bossong | located in the administrative territorial entity | M |
| Neuropharmacology Of Cannabinoid Receptor Ligands In Central Signaling Pathways | studies | Cannabinoid Receptor Ligands In Central Signaling Pathways |
| Cannabinoid Receptor Ligands In Central Signaling Pathways | studied by | Neuropharmacology Of Cannabinoid Receptor Ligands In Central Signaling Pathways |
| Aparasu | religious order | R |
| 23,359,114238 | point in time | 23 |
| J. Peña-Ceballos | father | J. Peña-Ceballos |
| Moloney | member of political party | P |
| Munteanu | located in the administrative territorial entity | T |
| Colleran | located in the administrative territorial entity | N |
| Liggan | league | B |
| Murphy | religious order | S |
| El-Naggar | country | H |
| Adjunctive Cenobamate | medical condition treated | Focal Epilepsy |
| Adjunctive Cenobamate | medical condition treated | Focal Seizures |
| Spective Study | subclass of | Study |
| Epilepsia | point in time | 2023 |
| Cenobamate For Treatment-Resistant Focal Seizures | medical condition treated | Treatment-Resistant Focal Seizures |
| Treatment-Resistant Focal Seizures | drug used for treatment | Cenobamate For Treatment-Resistant Focal Seizures |
| 1179 | point in time | 1179 |
| Kowalski | religious order | J |
| Maciejowski | religious order | M |
| Rosenfeld | religious order | W |
| E2311–E2322 | followed by | E2322 |
| Edinoff | has part | A |
| Rooney | award received | K |
| Sabbenahalli | located in the administrative territorial entity | S |
| Cornett | has part | E |
| Viswanath | religious order | O |
| Comprehensive Review And Clinical Implications | main subject | Clinical Implications |
| Wodschow | located in the administrative territorial entity | H |
| Nilsson | member of | M |
| Rungby | located in the administrative territorial entity | J |
| Neurodegen | has effect | Brain Metabolism |
| Erative Diseases | subclass of | Diseases |
| Sinaei Far | located in the administrative territorial entity | Z |
| Khalili | located in the administrative territorial entity | N |
| Keshavarz-Fathi | religious order | M |
| Mahmoudi | religious order | M |
| Rezaei | located in the administrative territorial entity | N |
| Diet In The Treatment Of Neuroblastoma | facet of | Neuroblastoma |
| Cancer Ther | field of work | Cancer |
| 15347354221150787 | followed by | 15347354221150787 |
| Dietary Therapies | main subject | Drug Resistant Epilepsy In Children |
| Verma Excellence In Research Award | instance of | Excellence In Research Award |
| Mittal | instance of | A |
| Cognition And Memory Impairment Attenuation Via Reduction Of Oxidative | has cause | Reduction Of Oxidative |
| Reduction Of Oxidative | has effect | Cognition And Memory Impairment Attenuation Via Reduction Of Oxidative |
| Antiepileptogenic Nux Vomica | medical condition treated | Epilepsy |
| Ethnopharmacol | instance of | Ethnopharmacol |
| Collotta | member of | A |
| Di Nora | league | A |
| Costanza | member of | G |
| Ruggieri | religious order | M |
| Falsaperla | religious order | R |
| Ketogenic Diet In Pediatric Seizures | instance of | Randomized |
| Mhanna | located in the administrative territorial entity | M |
| Al-Chalabi | religious order | M |
| Aladamat | located in the administrative territorial entity | N |
| Mahfooz | country | N |
| Winesett | instance of | S |
| Bessone | instance of | S |
| Kossoff | instance of | E |
| Ketogenic Diet In Pharmacoresistant Childhood Epilepsy | main subject | Pharmacoresistant Childhood Epilepsy |
| Ketogenic Diet For Human Diseases | main subject | The Underlying |
| Mechanisms And Potential For Clinical Implementations | facet of | Clinical Implementations |
| Signal Transduct | subclass of | Transduct |
| Ketogenic Dietary Therapies | field of work | Child Neurology |
| Indian Acad | instance of | Academia |
| 470–480 | point in time | 470 |
| Corsello | instance of | A |
| Trovato | religious order | C |
| Di Profio | instance of | E |
| Cardile | instance of | S |
| Campoy | league | C |
| Zuccotti | instance of | G |
| Verduci | instance of | E |
| Diamanti | instance of | A |
| Adolescents | has effect | Growth |
| 1067 | point in time | 1067 |
| Hartman | has part | A |
| Ketone Bodies In Epilepsy | medical condition treated | Epilepsy |
| Khabbush | instance of | A |
| Orford | award received | M |
| Heales | instance of | S |
| Medium-Chain Triglyceride Ketogenic Diet | medical condition treated | Metabolic Disorders |
| Sridharan | award received | B |
| Pathological Mechanisms | has part | Pathological Mechanism |
| 640–656 | followed by | 22 |
| Gasior | instance of | M |
| Vining | instance of | E |
| Rogawski | religious order | M |
| Neuropharmacology Of The Ketogenic Diet | main subject | Ketogenic Diet |
| 281 | part of | 292 |
| Tewari | instance of | B |
| Chaunsali | located in the administrative territorial entity | L |
| Sontheimer | has part | H |
| Neurouron-Glia Interactions In The Pathophysiology Of Epilepsy | subclass of | Pathophysiology Of Epilepsy |
| Carmant | located in the administrative territorial entity | L |
| Seizures And Epilepsy | author | Neuroscientists |
| Sanlier | located in the administrative territorial entity | N |
| Bryli´ Nski | located in the administrative territorial entity | Ł |
| Ł | contains administrative territorial entity | Bryli´ Nski |
| Dro ˙Zak | part of | P |
| Pelczar | instance of | M |
| Rejdak | located in the administrative territorial entity | K |
| Ketogenic Diets In The Management Of Lennox-Gastaut | location | Lennox-Gastaut |
| The New York Review Of Books | editor | John Updike |
| Nutrients 2022 | point in time | 2022 |
| Veggiotti | instance of | P |
| Tagliabue | located in the administrative territorial entity | A |
| Institute Of Neurology | parent organization | Irccs |
| Irccs | subsidiary | Institute Of Neurology |
| Mondino Foundation | named after | Mondino |
| Stefanidakis | religious order | M |
| Wilson | member of | C |
| Barrera | position played on team / speciality | L |
| Bounoutas | position played on team / speciality | G |
| Bumcrot | religious order | D |
| Ciulla | religious order | D |
| Leber Congenital Amaurosis Type 10 | has effect | Gene-Editing Approach To Restore Vision Loss In Leber Congenital Amaurosis Type 10 |
| Raghunath | religious order | M |
| Balancing Potential Benefits And Ethical Considerations Of Gene | followed by | Ethical Considerations Of Gene |
| Schorge | instance of | S |
| Gene Therapy In Epilepsy | facet of | Epilepsy |
| Goodspeed | instance of | K |
| Bailey | member of political party | R |
| Prasad | religious order | S |
| Cardenas | religious order | J |
| Holmay | instance of | M |
| Bilder | religious order | D |
| Minassian | league | B |
| Monogenic Epilepsy | subclass of | Epilepsy |
| Kleinstiver | league | B |
| Pattanayak | located in the administrative territorial entity | V |
| Nguyen | religious order | N |
| High-Fidelity Crispr-Cas9 Nucleases | subclass of | Cas9 Nucleases |
| Genome | has effect | Off-Target Effects |
| Nature 2016 | point in time | 2016 |
| E. E. Goldberg | instance of | E |
| Coulter | member of political party | D |
| Mechanisms Of Epileptogenesis | main subject | Neural Circuit Dysfunction |
| Jensen | member of sports team | F |
| Epileptogenesis In The Immature Brain | main subject | Emerging Mechanisms |
| Genome Editing Technology | use | Targeted Therapy |
| Human Diseases | has part | Mechanisms, Advances And Prospects |
| Mechanisms, Advances And Prospects | part of | Human Diseases |
| Fisher | instance of | A |
| Crispr-Mediated Genome Editing | facet of | Human Diseases |
| Crispr | use | Genomic Reprogramming In Neurological Disorders |
| 1845 | point in time | 1845 |
| Gøtzsche | position held | C |
| Woldbye | instance of | D |
| 695937 | point in time | 2121 |
| Fitzsimons | located in the administrative territorial entity | H |
| Epilepsia 2009 | point in time | 2009 |
| Simonato | instance of | M |
| Bennett | position held | J |
| Boulis | located in the administrative territorial entity | N |
| Castro | religious order | M |
| Lowenstein | religious order | P |
| Lowenstein | member of political party | D |
| Vandenberghe | located in the administrative territorial entity | L |
| Gene Therapy For Neurological Disorders | subclass of | Gene Therapy |
| Przybyla | instance of | M |
| Van Der Hoven | religious order | J |
| Delerue | ranking | F |
| Van Eersel | religious order | J |
| Ittner | located in the administrative territorial entity | L |
| P38ߖKinase Gene Therapy | subclass of | Gene Therapy |
| 2022,8,Eadd2577 | point in time | 22 |
| Kuchenbuch | instance of | M |
| Leblanc | religious order | G |
| Brooks-Kayal | league | A |
| Noebels | has part | J |
| Spencer | member of political party | D |
| Progress And Future Directions | main subject | Epilepsy |
| M. Weinberg | religious order | M. Weinberg |
| Samulski | member of political party | R |
| Mccown | instance of | T |
| Gene Therapy For Neurological Disease | part of | Next-Generation Approaches |
| Glorioso | religious order | J |
| A Brief Account Of Viral Vectors And Their Promise For Gene Therapy | main subject | Viral Vectors |
| Aav Vectors Applied To The Treatment Of Cns | use | Treatment Of Cns |
| Clinical Status And Challenges | facet of | Clinical Status |
| Neuroscience | studies | Brain |
| Cattaneo | located in the administrative territorial entity | S |
| Verlengia | located in the administrative territorial entity | G |
| Marino | member of political party | P |
| Bettegazzi | league | B |
| Gene Therapy For Epilepsy | developer | Npy |
| Epipm Consortium | field of work | Precision Medicine |
| 1219–1228 | point in time | 1219 |
| Yizhar | religion | O |
| Deisseroth | religious order | K |
| Wietek | religious order | J |
| Schmitz | religious order | D |
| Optogenetics At The Presynapse | location | Presynapse |
| Jennings | position held | J |
| Stuber | religious order | G |
| Neural Circuitry | studied by | Optogenetic |
| R. Stefanescu | member of political party | R |
| Shivakeshavan | member of political party | R |
| Talathi | instance of | S |
| Computational Models Of Epilepsy | facet of | Epilepsy |
| Seizure 2012 | point in time | 2012 |
| Huguenard | religious order | J |
| Optogenetics And Epilepsy | facet of | Epilepsy |
| Circuit Dysfunction | subclass of | Neurodevelopmental Disorders |
| Wickham | religious order | J |
| Kokaia | located in the administrative territorial entity | M |
| Optogenetics For Controlling Seizure Circuits | subclass of | Translational Approaches |
| 23,184,106234 | point in time | 23 |
| Gonzalez-Reyes | league | L |
| Durand | religious order | D |
| High Frequency Optogenetic Stimulation | subclass of | Seizure Suppression |
| Interneurons | has part | Interneurons |
| Microcircuit | part of | Cellular Design |
| Science 2014 | point in time | 2014 |
| Adhikari | instance of | A |
| Turnbull | member of political party | M |
| Gandara | religious order | C |
| Mcleod | position played on team / speciality | F |
| Escobedo-Cousin | instance of | E |
| Closed-Loop Optogenetic Control | subclass of | Optogenetic Control |
| Molecular Tools And Approaches For Optogenetics | main subject | Optogenetics |
| Maimon | religious order | B |
| Functional Optogenetic Stimulation | subclass of | Optogenetic Stimulation |
| J. Phillips | position held | J |
| Hutchings | position held | C |
| Djamgoz | award received | M |
| Clinical Potential Of Nerve Input To Tumors | main subject | Bioelectricity |
| Shikha | instance of | S |
| Translational Optogenetics | part of | Optogenetics |
| Papagiakoumou | located in the administrative territorial entity | E |
| Pouliopoulos | award received | A |
| Murillo | instance of | M |
| Konofagou | instance of | E |
| Evaluation Of Non-Invasive Optogenetic Stimulation | main subject | Optogenetic Stimulation |
| Transcranial Functional Ultrasound Imaging | subclass of | Imaging |
| Ultrasound Med | field of work | Ultrasound |
| Tonini | religious order | D |
| Magnetic | subclass of | Neurostimulation |
| Prospects | has part | Prospects |
| Nanotechnology | point in time | 2022 |
| Gopinath | religious order | N |
| Artificial Intelligence And Neuroscience | main subject | Neuroscience |
| Diwakar | instance of | A |
| Kirandeep | sibling | Mirpuri |
| Mirpuri | sibling | Kirandeep |
| Gandhi | religious order | T |
| Artificial Intelligence In Epilepsy | facet of | Epilepsy |
| Abualigah | located in the administrative territorial entity | L |
| Shambour | religious order | Q |
| Shambour | religious order | M |
| Abu-Hashem | country | M |
| Alsalibi | instance of | A |
| Gandomi | instance of | A |
| Medical Applications | subclass of | State-Of-The-Art Methods |
| Truong | located in the administrative territorial entity | N |
| Eshraghian | religious order | J |
| Kavehei | religious order | O |
| Neuromorphic Neuromodulation | subclass of | Neuromodulation |
| Neurosurgery | part of | Neurosurgery |
| Arxiv 2023 | part of the series | Arxiv |
| Shoaran | instance of | M |
| Pal Attia | member of political party | T |
| Crepeau | religious order | D |
| Kremen | located in the administrative territorial entity | V |
| Nasseri | religious order | M |
| Guragain | located in the administrative territorial entity | H |
| Steele | religious order | S |
| Sladky | instance of | V |
| Nejedly | instance of | P |
| Mivalt | instance of | F |
| Herron | religious order | J |
| Brain State | studied by | Physiology |
| Physiology | studies | Brain State |
| Adaptive Stimulation | subclass of | Stimulation |
| Author(S) | different from | Editor(S) |
| Editor(S) | different from | Author(S) |
| The Daily Mail | owned by | The Guardian |
| Ideas | subclass of | Property |